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Protein aggregation and physical stability are perpetual concerns in medicine and 
industry. Misfolded protein can form ordered protein aggregates, amyloids, which are 
associated with a host of neurodegenerative diseases in mammals and control heritable 
traits in fungi and yeast. Industrially, amorphous aggregates reduce the efficacy of 
protein-based therapeutics and activity of enzymes during production and storage. This 
work studies ion-specific and solvent-based effects on protein physical stability. We 
show that ion-specificity significantly affects amyloid formation kinetics, aggregate 
morphology, thermostability, frangibility, and, most intriguingly, prion infectivity in vivo. 
Forming amyloid in chaotropic or kosmotropic solutions generates predominately weak 
or strong prion variants, respectively. Ion-specific effects also influenced amorphous 
aggregation of model proteins and antibodies. To quantify protein – protein 
stability/affinity, we developed a rapid and reliable diffusion-based technique. Our 
technique was able to resolve relative differences in colloidal stability between various 
saline and saccharide solutions. In all, this dissertation expands our understanding of ion-






 This dissertation studies ion-specificity and water-mediated effects on protein 
physical stability in the contexts of prions, therapeutic proteins, and a biofuel producing 
enzyme. The main goal of this thesis is to further understanding and characterize ion-
specific (Hofmeister) effects on prion nucleation and therapeutic protein formulations.  
 
1.1 Protein Function and Folding 
Proteins are one of the four major classes of biomacromolecules essential for life. They 
function as catalysts, transporters, structural stabilizers, hormones, signaling molecules, 
storage units, and pathogen identifiers/neutralizers.
1
 In addition to being present in every 
living system, proteins are widely used in industry because of their exceptional 
specificity and extensive range of chemistries. Protein catalysts, known as enzymes, are a 
$2.5+ billion industry
2
 and are used in detergents, wine and beer making, baking, biofuel 
production, cosmetics, personal care, and the pulp and paper industry, among many other 
applications (for review on industrial enzymes see Kirk et al. (2002) or for a more 
extensive read on biocatalysts see textbook by Bommarius and Riebel-Bommarius 
(2004)).
3, 4
 Therapeutic proteins, namely antibodies, represent a $52+ billion market
5
 and 
treat a wide variety of cancers, autoimmune diseases, and inflammatory disorders.
6, 7
 All 
proteins, no matter their function, require proper folding and maintenance of their native 
folding state to be efficacious.  
 2 
Proteins are amino acid polymers, synthesized in a cell’s ribosome using a DNA 
blueprint.
1
 As the newly minted proteins exit the ribosome, they are disordered or 
“unfolded.” These polymers have high free energy because all amino acid residues, be 
they hydro-phobic or –philic, charged or neutral, are solvent exposed. The nascent 
peptide chains subsequently undergo a series of rapid conformational changes to ‘hide’ 
hydrophobic residues, reduce their solvent exposed area, and access the most 
thermodynamically favorable conformation, known as the native state.
8
 This process 
takes tens of milliseconds to a few seconds to complete, depending on the size of the 
molecule (for a more detailed discussion on protein folding see chapter 6 of Brandon and 
Tooze (1999)).
8, 9
 Only in the native state are proteins functional and active.  
Despite being the most thermodynamically favorable conformation, the native 
state is only marginally stable.
10, 11
 Small perturbations during or after folding can 




 (for reviews see Cleland 
et al.
12
 or Chi et al.
13
). Chemical degradation of proteins may occur by deamidation [of 
asparagines or glutamine residues], oxidation [of methionine, histidine, cysteine, tyrosine, 
or tryptophan residues], di-sulfide bond scrambling, hydrolysis, proteolysis, or 
fragmentation.
14, 15
 Physical instability occurs via self-association, aggregation, and/or 
denaturation.
6, 12, 13, 16
 This thesis will focus entirely on protein physical stability.  
 
1.2 Protein Aggregation and Physical Stability 
Two types of protein aggregates can form: (i) disordered, amorphous aggregates or (ii) 
ordered, fibrillar aggregates, known as amyloids.
17
 Figure 1.1 depicts a simplified 




Figure 1.1: Scheme of protein folding and aggregation pathways 
 
1.2.1 Amorphous Aggregation 
Native or denatured proteins may form amorphous aggregates. Aggregates made 
of native proteins form when proteins are either salted-out, isoelectrically precipitated, 
self-associate, or are over-produced in vivo.
13, 18
 Native aggregation is generally a 
reversible phenomenon and is often induced intentionally as part of a purification 
procedure (i.e. ammonium sulfate precipitation). Formation of amorphous aggregates 
from denatured proteins, in contrast, is almost always and unwelcome occurrence. These 
aggregates form when proteins denature due to some stress (to be discussed later this 
chapter) and previously ‘hidden’ hydrophobic residues become solvent exposed. A 
denatured protein may remain monomeric if stabilized by an appropriate concentration of 
surfactants, reducing agents, or strong denaturants.
19
 However, in the absence of a 
 4 
stabilizer, hydrophobic patches associate inter-molecularly with one another forming 
globular, amorphous aggregates.
20
 Although hydrophobic interactions are not covalent, 
such aggregation and denaturation is often irreversible.
13
  
This type of aggregation commonly afflicts biopharmaceutical production. 
Irreversible aggregation is a familiar and adverse occurrence during fermentation, 
purification, formulation, and storage.  In addition to being aesthetically undesirable and 
reducing product yield and efficacy, aggregates can incite an immune response within a 
patient.
21-23
 For industrial biocatalytic processes, aggregation is harmful because it 
destroys valuable catalyst and decreases or may even halt production.
24
   
 
1.2.2 Ordered Aggregation 
A class of proteins known as prions can misfold and aggregate to form ordered, 
fibrous, self-seeding structures, known as amyloids.
25
 Amyloids are associated with a 
host of terminal diseases in mammals, such as Creutzfeldt-Jakob disease, scrapies in 
sheep, “mad cow” disease, Parkinson’s disease, kuru, Chronic Wasting disease in deer 
and elk, and fatal familial insomnia, to name a few.
25-27
 Prions also exist in fungi and 
yeast, but are not terminal; rather, they control heritable, epigenetic traits.
28
 Most yeast 
prions are not considered to be toxic and are thought to be evolutionarily conserved 
because they may aid the organism under extreme or mercurial conditions.
28, 29
  However, 
controversy exists over the physiological effect of Sup35p, the most extensively studied 





Amyloids form when a naturally occurring, native protein undergoes a 
conformational change (spontaneously or when stressed) to a β-sheet rich conformer. 
Through favorable sterics and hydrogen-bonding opportunities, the ‘misfolded’ 
conformers aggregate along their β-sheets. The amyloid nuclei then induce other native 
protein of the same amino acid sequence to misfold and add onto one of the aggregate’s 
fiber ends.
31
  Once aggregates get long enough they fragment, forming two fibers, each of 
which perpetuates aggregation and may fragment further.
28, 32, 33
 In vitro fragmentation is 
likely due to a physical effect, such as shear or tensile stresses. In vivo fragmentation 
occurs when certain chaperones (heat shock proteins) attempt to un-aggregate amyloids. 
At normal chaperone expression levels, amyloid aggregation proceeds faster than the 
chaperones are able to un-aggregate; this results in the chaperones actually accelerating 





1.2.3 Influencing Aggregation 
Since aggregation is such a destructive phenomenon both medicinally and 
industrially, much research has been dedicated to understanding which factors govern and 
contribute to it.
12-14, 16, 18, 20, 24
  The physical stability of proteins is mainly dictated by 
amino acid sequence and environmental conditions.
16, 17
 Increasing protein stability 
through structure-guided mutagenesis can be highly-effective and is often necessary to 




 Environmental conditions are more easily altered and can have profound 
effects on protein stability, as will be chronicled in the chapters to come.  
 
1.3 Environmental Conditions and Physical Stability 
Every protein is unique in its amino acid composition and, as a result, has distinct 
stability behavior. The extent to which a given environmental condition affects a protein 
is protein-specific; however, certain factors have been identified as being significant in 
affecting the physical stability of all proteins. These factors include, but are not limited 
to: solution pH, temperature, surfactants, relative humidity, oxygen content, shear or 
shaking, co-solutes, preservatives, salt type and concentration, and light/irradiation.
13, 18
 
This thesis studies in detail the effects of salt type and concentration, temperature, and 
co-solutes (namely, sugars). pH is often considered to be one of the most important 
determinants of stability
18
 and is studied tangentially in this work. The optimal pH for the 
proteins studied in this work was known a priori, thus further study was not necessary. 
Potential future work regarding pH is discussed in the final chapter.  
 
1.3.1 Salt Effects 
Salts are present in every living system and pharmaceutical formulation. They are used as 
buffering, tonicity, acidifying, and stabilizing agents.
39
 Salts exert both non-specific and 
ion-specific (Hofmeister) effects on proteins; consequently, both the salt concentration 




Salt concentration controls the strength of electrostatic interactions between 
charged groups intra- and inter-molecularly in a non-specific manner.
13
 Low salt 
concentrations are necessary for maintaining pH, ensuring tonicity, and stabilizing 
proteins. As ionic strength increases, Debye lengths decrease and charges become 
screened, which reduces electrostatic repulsion between proteins. How charge screening 
affects aggregation depends strongly on the pH of the solution, which dictates the 
charged state of a protein. If addition of salt tends toward neutralizing the protein surface, 
then unfolding is likely to occur; otherwise, stability will likely increase.
18, 46, 47
 
Generally, some level of salt is requite for stability, but high ionic strengths will cause 
denaturation and/or aggregation.  
The importance of salt type was first described by Franz Hofmeister (1888). He 
found that hen egg white lyzosyme (HEWL) precipitated at different ionic strengths 
depending on which ion was present in solution. He ranked the ions according to how 
readily they would precipitate HEWL;
48
 this ranking is now known as the Hofmeister 













































Hofmeister divided salts into two major groups, chaotropes and kosmotropes, 
according to how they interacted with protein. Chaotropes (khaos, Greek for chaos or 
disorder) are ions that decrease surface tension, increase protein solubility, and cause 
denaturation.
49, 50
 Chaotropic ions are those to the left of, and including, chloride and 
potassium. Extreme chaotropic agents include urea and guanidine hydrochloride, which 
 8 
are used to break up inclusion bodies and cleanse chromatography columns. Ions to the 
right of chloride and potassium are known as kosmotropes (kosmos being Greek for 
order). These ions increase surface tension, decrease protein solubility, and stabilize the 
native state.
49, 50
 Many osmolytes, such as sugars and amino acids, act as kosmotropic 
agents.
51
 Hofmeister’s finding that kosmotropes (namely sulfates) caused native 
precipitation was a major discovery in biochemistry. Sulfate precipitation was one of the 
first method of protein purification
52
 and  is still commonly used because it is one of the 
most economical and easiest purification techniques.
53, 54
  
 The origin of ion-specific or Hofmeister effects is not fully understood, but the 
hydration state of ions is thought to play a major role. Ions can be thought of as spheres 







) the distance between the point charge and water gets larger. At 
some distance, water has a stronger interaction with itself than with the ion; this distance 
marks the difference between chaotropes and kosmotropes (~1.78 Ǻ and ~1.06 Ǻ ionic 
radii for monovalent anions and cations, respectively).
55
 The larger, poorly-hydrated ions 
are chaotropes; whereas the smaller, well-hydrated ions are kosmotropes.
50, 55
 As a result 
of differences in water affinity, chaotropes will accumulate at hydrophobic interfaces, 
such as an air-water or protein-water interface; kosmotropes will preferentially interact 





 proposed the preferential interaction model to 
explain why kosmotropes [and osmolytes, such as sugars,] stabilize proteins. The model 
states that exclusion of kosmotropes from the protein-water interface creates a layer of 
pure water around the protein. This exclusion volume is thermodynamically unfavorable 
 9 
because the solvent prefers to interact with itself rather than the protein, elevating the 
interfacial tension. Thus, the system works to minimize the high energy interfacial area. 
The added interfacial tension makes protein expansion (i.e. denaturation) more energy 
intensive; as a result, protein is forced into its most compact conformation: the native 
state.
49, 51, 55, 60
  In concentrated salt solutions, the driving force to minimize interfacial 
area is large enough to cause native aggregation and/or amorphous precipitation through 
the coalescence of excluded volumes.
59
  
The molecular mechanism of why chaotropes denature proteins is still somewhat 
murky; however, a few theories attempt to rationalize it.
55, 60, 61
  As chaotropes have 
lower affinity for water, they tend to accumulate at hydrophobic surfaces, such as that of 
a protein.
55
 As the concentration of chaotrope in solution increases, more ions remain in 
the bulk solution, making the bulk overall more amenable to hydrophobic residues 
because of potentially favorable hydrogen-bonding and van der Waals interactions. Kita 
et al.
60
 suggest that denaturation then occurs because protein – solvent interactions 
become more thermodynamically favorable than existing intra-molecular interactions. In 
such a case, proteins then maximize their solvent exposed area and become denatured. 
Muller
61
 adds that protein solubility is increased in chaotropic solutions because of the 
favorable solvent – protein interactions.  
Denaturation in chaotropes is highly concentration dependent. At low 
concentrations (<300 mM), chaotropes are actually seen to stabilize protein; at 
intermediate concentrations, they denature proteins, but the driving force for amorphous 
aggregation is greater than the protein – solvent interactions; at high concentrations (8 M 




1.3.2 Temperature  
Proteins operate in a narrow temperature window and slight perturbations can derail an 
industrial process or cause a therapeutic protein is irreversibly aggregate. Enzymes are 
most active at elevated temperatures; hence industrial processes try to maximize the 
operating temperature without thermally denaturing their catalyst.
24, 63-65
 Such 
considerations will be discussed in a case study on a biofuels producing enzyme, Cel7A, 
in chapter 7. For further reading on temperature considerations and biocatalysts see 
reviews by Polizzi et al.
24
 and Bommarius and Broering.
64
 For therapeutic proteins, high 
thermal tolerance is advantageous because processing, transportation, and storage are 
more economical and straight-froward when performed at ambient temperature, as 
opposed to under refrigerated conditions.
39
  
Temperature is often considered to be the most important factor contributing to 
protein stability, or lack thereof.
13, 18, 64
  The thermodynamic stability of the native state is 
typically characterized by the free energy of unfolding ΔGunfold, as shown in Figure 1.2. 
As temperature increases, a protein will expand and ultimately unfold as it reaches its 
melting temperature Tm at ΔGunfold = 0. By convention, the melting temperature is defined 
as the temperature at which the protein is half way through the unfolding process.
18, 24
 





Figure 1.2: Relation between temperature and protein thermodynamic stability 
 
Proteins can also unfold when temperature is decreased. Aggregates can and do 
form due to cold denaturation; however, it is not uncommon for such denaturation and 
aggregation to be reversible because the hydrophobic interactions that cohere aggregates 
are dulled at lower temperatures.
18
 Rees and Robertson give a more detailed account of 






Sugars and other osmolytes are often used to stabilize proteins in solution or during 
lyophilization.
6, 67, 68
 The mechanism of sugar stabilization in solution is thought to derive 
from the preferential hydration of proteins and exclusion of sugar from the protein – 
water interface; this is known as the preferential interaction model and is the same as was 
discussed earlier in the context of kosmotropic ions.
51, 59, 67, 69











causes elevated interfacial tension and, by Le Chatelier’s principle, the system will 
minimize the unfavorable water – protein interface.  Protein is then forced into its most 
compact conformation, which is the native state.
51
  
 Sugars are often added to protein solution to prevent cold denaturation during 
lyophilization. As temperature rapidly decreases, sugars become vitrified and create a 
glassy matrix. Proteins are evenly dispersed throughout this matrix and are stabilized 
because their conformational mobility is restricted.
70-73
 Sucrose, glucose, and trehalose 




 Sugars are also used to stabilize proteins in vivo (for review see Davis-Searles et 
al. 
74
). The most marked effects are in organisms that may undergo anhydrobiotic stress 
(Greek for life without water), such as brine shrimp, fungal spores, baker’s yeast, 
tardigrades, and certain desert plants.
75-77
 During anhydrobiosis, these organisms are in a 
cryptobiotic state (Greek for hidden life), which is a kind of suspended animation, due to 
extreme dehydration.  Under such desiccating conditions, these organisms accumulate 
large stores of disaccharides, such as sucrose or trehalose. The disaccharides become 
vitrified and stabilize the organisms’ cell membranes and proteins through hydrogen-




1.4 Proteins in this Study 
This thesis will study the physical stability of a yeast prion protein (Sup35p), two model 
proteins (lysozyme and bovine serum albumin), a pair of human immunoglobulin G1 
antibodies (hIgG1), and a cellulase (Cel7A). Sup35p is a translation termination sub-unit 
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in yeast, capable of forming ordered aggregates. This yeast prion is often used as a proxy 
for mammalian prions because it is easier to express and safer to handle. Lysozyme is 
14.3 kDa muramidase that hydrolyzes bacterial cell walls. It is often used as a model 
protein because it is relatively inexpensive, available at high purity, and can be 
approximated well as a sphere.  Bovine serum albumin (BSA) is another model protein. It 
is a 66.8 kDa protein that is used as a nutrient, enzyme stabilizer, and as non-specific 
binding molecule.
43
 The two hIgG1s studied are 145 kDa antibodies and only differ in 
that one is glycosylated and the other is not. The pair was provided by Bayer Pharma and 
their function is unknown.
44
 Cel7A is a 52 kDa enzyme that assists in the hydrolysis of 




1.5 Map of Dissertation 
This thesis is organized in the following manner. Chapters 2 and 3 study salt-effects on 
Sup35p. Chapter 2 looks at salt-specific effects on Sup35NM (a truncated version of 
Sup35p) nucleation kinetics in vitro and how infectious those amyloids are in vivo. 
Chapter 3 investigates aggregation kinetics of Sup35NM from three closely related 
Saccharomyces species in different saline conditions. Cross-species seeding experiments 
are then studied with and without the influence of salts. Chapters 4 through 6 study the 
effect of anions and sugars on protein – protein interactions and if they can be quantified 
through diffusivity measurements. Chapter 4 is a proof-of-concept paper, which relates 
fast diffusivity measurements in low salt conditions to long-term, high salt aggregation 
experiments using two model proteins. Chapter 5 tests and expands on the technique 
outlined in Chapter 4 using a pair of hIgG1 antibodies. This chapter investigates the 
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effects of temperature, ion-specificity, and glycosylation on the stable protein – protein 
interactions and aggregation. Chapter 6 examines whether protein diffusivity correlates 
well to aggregation and protein melting temperature in saccharide solutions. The 
aglycosylated hIgG1 used in Chapter 5 was the focus of this study. Chapter 7 investigates 
the thermostability of Cel7A from Trichoderma reesei and its two domains. Chapter 8 is 
the final chapter which summarizes the previous seven chapters and offers suggestions 
for further research.  
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ION-SPECIFIC EFFECTS ON PRION NUCLEATION AND STRAIN 
FORMATION 
This chapter is adapted from a research article bearing the same title submitted for 
publication in March 2013. Hasan Khosravi, Kathryn Bruce, Megan Lydon, Sven 
Behrens, Yury Chernoff, and Andreas Bommarius contributed to this work. 
 
2.1 Abstract 
Ordered, fibrous, self-seeding aggregates of misfolded proteins known as amyloids (and 
their transmissible versions, prions) are associated with uniformly terminal mammalian 
diseases. In fungi, amyloids control phenotypic traits. Curiously, a given protein may 
adopt multiple distinct amyloid conformations, known as “variants” or “strains,” each of 
which leads to a distinct disease pattern or phenotype. In mammals and fungi, the growth 
of amyloid fibers follows a two-step pattern of initial nucleation followed by fiber 
elongation. The kinetics of nucleation is thought to critically influence amyloid 
conformation and strain properties. In this work, we study the effect of Hofmeister ions 
on nucleation and strain generation by the prion-domain-containing fragment (Sup35NM) 
of a yeast protein Sup35p, the [PSI
+
] prion determinant. We show that strongly hydrated 
anions (kosmotropes) initiate nucleation quickly and cause rapid fiber elongation, 
whereas poorly hydrated anions (chaotropes) delay nucleation and do not greatly affect 
the elongation rate. Amyloids formed in kosmotropes are less thermostable, shorter, and 
propagated [PSI
+
] more effectively in vivo compared to amyloids formed in chaotropes. 
We suggest that these phenomena result from differences in the biochemistry of 
 22 
Hofmeister ions: chaotropic anions adsorbs to the prion recognition domain, inhibiting 
sequence recognition and amyloidogenesis; whereas kosmotropic anions do not affect 
sequence recognition and may accelerate amyloid formation by inducing a depletion 
attraction between the templating aggregate surfaces and not aggregated protein. Our 
work shows that the ionic composition of a solution not only influences the kinetics of 
amyloid nucleation but also determines the amyloid strain that is preferentially formed.  
 
2.2 Introduction 
Amyloidoses are disorders marked by the deposition of fibrous protein aggregates 
(amyloids) within an organism.
1, 2
 In mammals, these disorders include widespread, 
sporadic, or familial neurodegenerative diseases such as Alzheimer’s and Parkinson’s 
disease. Infectious amyloids, termed "prions", cause transmissible spongiform 
encephalopathies or prion diseases, which include Creutzfeldt-Jakob disease in humans 
and “mad cow” disease in cattle (for review see refs.
1, 3, 4
). Not all amyloidoses are 
pathological, however, as in the case of the mammalian melanocyte Pmel17 which is 
biologically beneficial 
5
. In yeast and fungi, there is an ever-growing list of prions which 
control specific phenotypic traits and may have pathological effects 
6-9
. Amyloids are also 
formed spontaneously in the preparations of protein- or peptide-based drugs upon storage 




2.2.1 How Amyloids Form 
The basic scheme of amyloid formation appears to be the same for all amyloidogenic 
proteins, mammalian or fungal. The process typically originates with a morphological 




. For many, maybe most 
12
 proteins, such a conversion can occur in vitro under 
extreme solution conditions (high temperature and low pH), as in the cases of lysozyme, 
transthyretin, and insulin 
13-16
. Prion proteins, however, spontaneously misfold under 
physiological conditions. Regardless of how the conformers were induced, the β-sheet-
rich peptides aggregate to form nuclei. Solution conditions play a great role in 
determining the rate of nucleation and the structure of the nucleus 
17-19
; however, this 
relationship is not yet clearly understood. After nucleation, other peptides of the same 
amino acid sequence are recruited to the aggregate in a unidirectional manner, analogous 
to “one-dimensional crystallization” (Figure 2.1). 
 
 
Figure 2.1: Basic scheme of amyloid nucleation and propagation 
2.2.2 Sup35p 
Yeast prions are often used as a model for mammalian prions because yeast prions 
aggregate through the same mechanism, are easier to express, are inexpensive, and, most 
importantly, do not pose a biohazard threat to the experimenter. The most extensively 
studied yeast prion is Sup35p. Sup35p, also known as eukaryotic release factor 3, is a 





Figure 2.2: Domains of Sup35p and their amino acid (aa) composition 
 
 The C-terminal domain is responsible for the protein’s biological function; the 
middle (M) domain’s function is unknown; the N-proximal domain is prion domain. The 
glutamine (glu) and aspargine (asn) rich N domain can misfold and form aggregates by 
aligning glu and asn residues inter-molecularly, forming a steric zipper (Figure 2.3):
6, 21
 
Since only the N domain is required for amyloid formation, a truncated version of 
Sup35p composed of just the N and M regions, known as Sup35NM, is often used for in 
vitro experimentation, as is done in this thesis. The N domain alone is difficult to express, 
is not very water soluble, and aggregates too rapidly to study; addition of the M domain 





Figure 2.3: Steric zipper between β-sheets from aggregating Sup35p molecules. Image is 




 Sup35p is the protein determinant of the [PSI
+
] trait. Cells containing the prion 
form of Sup35p are said to be [PSI
+
]; those without the prion form are denoted [psi
-
]. A 





 If Sup35p is not aggregated ([psi
-
] cells), it continues to function as a 
translation termination co-factor and will stop translation of the Ade1 protein prematurely 
[because the nonsense mutation introduced a stop codon in the middle that gene] (Fig. 
2.4c). Ade1p allows for the biosynthesis of adenine; hence in media devoid of adenine (-
ade media), cells cannot grow. Additionally, cells grown on non-selective YPD media 
will attempt to produce adenine, but the biosynthesis will not go to completion [because 
Ade1p is not present] and a red intermediate accumulates in the cells (Fig. 2.4a). If 
Sup35p is inactivated in aggregates ([PSI
+
] cells), then read-through of the nonsense 
mutation occurs and Ade1p is properly translated (Fig. 2.4c). Cells can now grow on –
ade media. On YPD media, cells can process the red intermediate that would form in [psi
-






Figure 2.4: Characteristically (a) red [psi
-
] cells and (b) white [PSI
+
] cells. (c) Sup35p is 
soluble and functional when not aggregated (left). When Sup35p is sequestered in 
aggregates (right), the protein cannot perform its function and read-through of the 





2.2.3 Environmental Factors and Strains  
Two main factors dictate the folding state, nucleation, and aggregation propensity of 
proteins: the primary sequence and environmental conditions 
23-25
. The high primary 
sequence specificity of amyloid propagation has been clearly demonstrated through 
mutational studies, construction of synthetic prion, and species barrier studies 
26-31
 ; 
however, the mechanism of a curious phenomenon in prion biology where a given 
peptide can misfold into a variety of distinct amyloid structures, each leading to a distinct 
transmissible or inheritable phenotype 
22, 32, 33
, remains unclear. The question arises as to 
whether environmental factors, such as pH, co-solutes, shear, temperature, and ionic 
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strength, can elicit these different aggregation states giving rise to different prion 
“strains” or “variants.”  
Prion strains have been extensively studied for the yeast prion protein Sup35p, the 




. In vitro studies typically employ a 253-
residue, amyloid-forming fragment of Sup35p, called Sup35NM. Sup35NM has been 
shown to predominantly form different strains of [PSI
+
] when nucleation occurs at 
different temperatures 
17, 39-42
. Amyloids formed in vitro at 4 ⁰C (Sc4) and 37 ⁰C (Sc37) 
preferentially induced “strong” and “weak” [PSI
+
] strains, respectively, when transfected 
into Saccharomyces cerevisiae 
39
. These different [PSI
+
] strains were shown to form at 
different rates 
40
, through different pathways 
17
, and create distinct structures 
41
. Notably, 
phenotypically “strong” strains are characterized by less stable physical structure and 
shorter amyloid core region, as quantified by SDD-AGE and solid state NMR; the 
opposite is true of phenotypically “weak” strains. This is due to the fact that efficient 
prion propagation in vivo occurs via a chaperone-mediated fragmentation of aggregates 
that generates new seeds. Amyloids that are physically more stable are less efficiently 
fragmented and therefore are phenotypically weak 
6
.   
Similar to temperature, the ionic composition of the solution has been shown to affect 







, and Sup35NM 
18
; however, the effect of solution 
composition on amyloid structures and biological effects was not studied in detail. The 
present work relates the differences in aggregation kinetics of Sup35NM caused by 
different salts to the structures and propagation parameters of amyloids formed in 
respective conditions. We find striking differences between aggregates formed in the 
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presence of kosmotropes (well-hydrated anions) versus chaotropes (poorly hydrated 
anions). Overall, our data show for the first time that the ionic composition of the 
solution modulates the structural patterns of nucleated amyloids. 
 
2.3 Materials and Methods 
 
2.3.1 Sup35NM Purification and Polymerization 
Sup35NM was heterologously produced in HMS174 (pLysS) E.coli (Novagen) using a 
pET20b-SUP35NM-(His)6 expression vector as previously published 
47
. Ni-NTA 
purification was performed as previously described 
18
. Sup35NM was resuspended in 
PBS (pH 7.4) containing 0.5 M of a given sodium salt to a final concentration of 10 μM 
and allowed to rotate at 20 rpm at room temperature for 48 hours to polymerize. Samples 
were frozen at -80 ⁰C until used.  
 
2.3.2 Kinetic Assay  
Solutions of thioflavin T (Sigma Aldrich) were prepared daily in PBS. Aggregation 
experiments were conducted in quadruplicate with final ThT and Sup35NM 
concentrations of 100 μM and 10 μM, respectively, and containing a sodium salt. 
Polymerization was initiated by shaking samples at 18 Hz linearly at 27 ⁰C in a BioTek 
Instruments Synergy H4 Hybrid Multi-Mode Microplate Reader (Winooski, VT). 
Fluorescent readings were taken every 15 minutes for 12 hours using an excitation 
wavelength of 440 nm and emission wavelength of 480 nm. Data was modeled using a 
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non-linear MATLAB sigmoidal curve fitting program (available at 
http://bommarius.chbe.gatech.edu/research).  
 
2.3.3 Thermostability Assays 
Amyloid samples were centrifuged and washed to remove residual salt. Amyloids were 
resuspended in 100x diluted PBS. For SDS-PAGE gel-entry assay, aggregates were held 
for 15 minutes in a pre-heated thermal block, then run on an acrylamide gel.  
Densitometry analysis was performed using ImageJ software. For the DLS technique, 
resuspended amyloids were sonicated, then covered with silicon oil (to prevent solvent 
evaporation), and subjected to a temperature ramp protocol in a Malvern Zetasizer Nano 
ZS90 (Worcestershire, UK). The protocol increased the temperature by 1⁰C, equilibrated 
the sample for 2 minutes, and then took a single size measurement for 1 minute. For these 
size measurements, the z-average of the amyloid diffusion coefficients was obtained from 
a second-order cumulant fit to the scattering intensity autocorrelation function, and 
translated into a hydrodynamic diameter via the Stokes-Einstein relation. 
 
2.3.4 Imaging  
Aggregates were first washed and resuspended in DI water. For TEM images, aggregates 
were adsorbed on formvar carbon coated 200 mesh copper grids by dropping 5 μL of 
protein solution onto the grid.  Fibers were negatively stained using 2 μL of a 3% (w/v) 
uranyl acetate solution.  After 60 seconds of staining, the sample was washed with 
deionized water and dried at 40 °C overnight. Images were acquired with a JEOL JEM 
100CX II electron microscope operating at 100 kV. The microscope was equipped with a 
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LaB6 filament and side-mounted 4.2 megapixel FLI CCD camera.  Bright-field images 
were acquired at magnifications of 14,000-80,000 x with a 300 µm second condenser 
aperture, 40 µm objective aperture, and “spot size” of 2.  MaxIm DL software was used 
for imaging. 
For AFM samples, 20 μL of aggregate solution was allowed to adsorb onto freshly 
cleaved mica for 20 minutes. The sample was then washed and dried at room temperature 
overnight. Images were acquired using a Veeco Dimension 3100 AFM (Plainview, NY) 
with a >10 nm AppNano silicon tip in tapping mode. Measurement of individual fibers 
was conducted manually offline using NanoScope Analysis software. 
 
2.3.5 Semi-Denaturing Detergent Agarose Gel Electrophoresis (SDD-AGE) 
SDD-AGE experiments were conducted on amyloid formed in vitro in either perchlorate 
or sulfate as previously published 
48
, except 0.1 % SDS added to the transfer buffer.  
 
2.3.6 Electrophoretic Mobility 
Electrophoretic mobility measurements were conducted using a Malvern ZS90 Zetasizer. 
Monomeric Sup35NM was suspended in water and pH’d using very dilute NaOH or HCl 
solutions. The isoelectric points (pI or IEP) was determined by finding the pH at which 
the electrophoretic mobility was zero (i.e. the protein carried no charge). 
 
2.3.7 Transfection  





used for all experiments 
49
. GT17 contains a nonsense mutation ade1-14 (UGA) in the 
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ADE1 gene, which causes premature translational termination of Ade1 protein synthesis 
in [psi
-
] cells, as described above. Again, [psi
-
] cells cannot grow on media lacking 
adenine and appear red on YPD media; [PSI
+




In vitro generated amyloid was washed with DI water, sonicated, and then 
transfected into yeast along with a URA3-marker plasmid using a protocol described by 
Tanaka et al.  
39
 with the following modifications: SCE buffer did not contain 
dithiothreitol (it was added separately to the sphereoplasting solution); PEG buffer was 
prepared with (44% w/v PEG 3350); top agar concentration was 0.8%, and it was 
incubated at 42°C to prevent solidification.  
Transfectants were transferred to –ura selective media then velveteened onto 
YPD and -ade for phenotypic determination of strain. 
 
2.4 Results  
2.4.1  Ion-specificity and Sup35NM Aggregation Kinetics.  
We first examined the effects of salt type and salt concentration on Sup35NM amyloid 
formation in vitro via a fluorescence assay using the amyloid-binding dye thioflavin T 
(ThT) 
50
. A typical aggregation profile is presented in the inset of Figure 2.6A. The 
classical sigmoidal-shape of these data is indicative of nucleation-dependent (ND) 
aggregation. ND aggregation is characterized by three phases: lag phase, fiber elongation, 
and mature fibril 
11














,                (Eqn. 2.1) 
 
where A is the normalized amplitude, k is the fiber elongation rate constant, t is time, t1/2 





  ,                 (Eqn. 2.2) 
The duration of the lag and fiber elongation phases varied significantly between ions 
and salt concentrations (Fig. 2.5). The rate of fiber elongation (Fig. 2.6A) was increased 
and the lag time (Fig. 2.6B) diminished in the presence of kosmotropes (shown in blue) 
in an ion-specific and concentration-dependent manner. Chaotropes (shown in orange) 
dramatically lengthened the lag time in an ion-specific and concentration-dependent 
manner (Fig. 2.6B). Strong chaotropes or kosmotropes (shown as darkness of hue) 
accentuated these effects. 
 
 
Figure 2.5: Examples of thioflavine T aggregation kinetic data and model fits for a 
strong kosmotrope, sulfate (A), and a strong chaotrope, perchlorate (B), at the following 
salt molarities: 0.4 (□), 0.3 (○), 0.2 (∆), 0.1 (◊), and 0.025 (upside-down triangle). 
MATLAB non-linear regression models are shown in solid black line (Eqn. 2.1). 
 
 33 
Ostensibly, chaotropes stabilized the monomeric form of Sup35NM while 
kosmotropes promoted formation of the polymeric (aggregated) form, confirming the 
“inverse” Hofmeister trend previously observed
18
. Having confirmed that ion-specific 
effects greatly affect aggregation rate, we examined the structural and biological effects 
of these differing rates. 
 
Figure 2.6: In vitro Sup35NM aggregation kinetics determined using thioflavine T fluorescence. 
A characteristic aggregation experiment and model parameter determination is shown in the inset 
to (A). Chaotropes are shown in orange and kosmotropes are shown in blue. The background 
buffer, PBS, without added salt is shown in grey. The elongation rate constants (A) and lag times 
(B) are shown over four salt concentrations. 
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2.4.2 Temperature Stability and Frangibility  
We hypothesized that a correlation exists between the time aggregates take to form in 
different salt solutions and the compactness and stability of the resulting aggregate 
structure. This hypothesis is motivated by an analogous kinetics-structure relation known 
from the aggregation of isotropically interacting colloidal particles 
54
 and by the general 
notion that slower aggregation kinetics allows for the exploration of a larger 
configuration space and the realization of lower energy aggregate states. According to 
this expectation, a faster forming amyloid would contain more imperfect intermolecular 
bonds and have a smaller amyloid core, similar to Sup35NM amyloids preferentially 
formed at low temperature. On the other hand, a slow forming amyloid would create a 
compact structure with well-formed intermolecular bonds, allowing for a larger, more 
robust amyloid core, as in Sup35NM amyloids preferentially formed at high temperature 
39
. We tested this prediction using two different techniques, both applied to amyloids 
produced in the presence of various salts (Fig. 2.7C). In both cases, amyloids were 
subjected to a temperature ramp and either particle size was measured using dynamic 
light scattering (DLS) or the proportion of non-aggregated (monomeric) protein was 
determined based on its ability to enter the SDS-PAGE gel (gel entry assay). The 
temperature of disaggregation TD as determined by DLS correlates (Fig. 2.7B) well with 
that determined by gel entry assay (Fig. 2.7A). Despite slight differences in TD caused by 
qualitative differences in the two techniques, both assays indicated that amyloids created 
in the presence of kosmotropes had lower thermostability than those formed more slowly 
in chaotropic conditions.  
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Figure 2.7. Analysis of the amyloid thermostability. Examples of the gel entry assay are 
shown in (A) and DLS disaggregation temperature ramp in (B). Gel entry assay and DLS 
determined thermostability of amyloids (C). Chaotropes are shown with open icons, 
kosmotropes are shown with closed icons. 
 
Amyloid frangibility was assessed by fractionating polymers by sizes using semi-
denaturing detergent agarose gel electrophoresis (SDD-AGE) after sonication. Amyloids 
formed in the presence of sulfate (ScS), a strong kosmotrope, were more readily 
fragmented by sonication than amyloids formed in perchlorate (ScP), a strong chaotrope 
(Fig. 2.8A). This result also confirms that ScS is physically less stable than ScP. Notably, 
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non-sonicated ScP fibers could not enter the gel whereas ScS fibers could, indicating that 
ScP fibers are larger than ScS fibers (Fig. 2.8B). 
 
 
Figure 2.8: SDD-AGE gels comparing ScS and ScP susceptibility to sonication (A) and 
size (B). Both lanes in (A) are sonicated. Size is compared in (B) by what is able to enter 
the gel. 
 
The differences in stability, like differences in kinetics (Fig. 2.6), between amyloids 
formed in the presence of intermediate Hofmeister ions were less pronounced than for 
ScS and ScP (Fig. 2.7C). Ion-specific effects are more apparent when comparing ions at 
the extremes of the Hofmeister series, as exemplified by comparing ScS and ScP.  
 
2.4.3 Microscopy Analysis of Amyloids Produced in the Presence of Various Salts  
Transmission electron microscopy (TEM) of Sup35NM amyloids formed in the presence 
of different salts revealed a systematic structural variation that follows an inverse 
Hofmeister trend. Amyloids formed in chaotropes were visibly most ordered compared to 
those formed in kosmotropes (Fig. 2.9A-E). The most pronounced difference is seen by 
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comparing the highly-ordered, helical fiber bundles of ScP aggregates (Fig. 2.9A) to the 
grainy ScS aggregates (Fig. 2.9E). The strong contrast between amyloids formed in 
chaotropes (Fig. 2.6F) and kosmotropes (Fig. 2.10G) was also confirmed by using atomic 
force microscopy (AFM).  
 
 Figure 2.9: Bright-field TEM images of negatively stained amyloid fibers. Amyloids were 
formed in the presence of the following salts: perchlorate (A), nitrate (B), chloride (C), acetate 
(D), and sulfate (E). 
 
AFM was employed to measure average fiber lengths. All conditions produced log-
normal fiber length distributions. The difference in lengths as determined by AFM 
follows an inverse Hofmeister trend. Fibers formed in chaotropes, such as perchlorate and 
nitrate (Fig. 2.10, A and B), were markedly longer than fibers formed in kosmotropes, 





Figure 2.10: AFM analysis of the Sup35NM amyloids formed in perchlorate (A), nitrate 
(B), chloride (C), acetate (D), and sulfate (E). Scale bar = 200 nm. Length distributions 
were fit to a log-normal probability density function, shown as black curve 
2
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 where L, μ, and σ are fiber length, mean, and standard 
deviation, respectively (44). Close-up images of amyloid formed in nitrate (F), a 
chaotrope, and sulfate (G), a kosmotrope, are shown to contrast their structures. 
 
2.4.4 Phenotypic Characterization of Prion Variants Produced in the Presence of 
Different Salts 
 Next, we investigated if the different amyloid structures formed in different salts would 
lead to different strains of the [PSI
+
] prion upon transfection into the yeast cells. 
Conversion of Sup35p into a prion ([PSI
+
]) form results in a defect of translation 
termination. The degree of Sup35p inactivation depends on the prion variant or strain and 
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leads to a spectrum of [PSI
+
] phenotypes ranging from white (strong [PSI
+






Notably, phenotypically strong [PSI
+
] strains typically correspond to the physically 
less stable amyloids; the opposite is true of weak variants 
40, 41
. This is rationalized by the 
ability of frangible, fast aggregating fibers to break and create more fiber ends at which 
soluble Sup35p can be quickly recruited to the fiber; conversely, more robust, slowly 
aggregating fibers create fewer fiber ends and therefore cannot immobilize and inactivate 
soluble Sup35p as efficiently in vivo. Thus, we hypothesized that smaller, frangible, more 
rapidly aggregating fibers, such as ScS, would lead to phenotypically strong [PSI
+
], 




This hypothesis was tested by transfecting in vitro formed Sup35NM amyloids into S. 
cerevisiae cells (Fig. 2.11A). For simplicity, [PSI
+
] strains were divided into three classes 
- “strong”, “intermediate,” and “weak” (Fig. 2.11B). All three classes were curable by 




. In line 
with our hypothesis, the slowly forming, stable ScP amyloids predominantly induced 
weak [PSI
+
] (Fig. 2.11C & D); whereas the fast-forming, frangible ScS aggregates 
primarily induced strong [PSI
+
] (Fig. 2.11C & E). A strain continuum was produced by 
transfected amyloid formed in anions that fall between perchlorate and sulfate (Fig. 
2.11C). A summary of the transfection results along with tranfection efficiencies is 
presented in Table 2.1. These results resemble data obtained for Sup35NM amyloids 
formed at different temperatures 
39
. We have repeated Sup35NM aggregation at different 
temperatures (4⁰C and 37⁰C) followed by transfection and confirmed that a variety of 
 40 
prion variants was generated at each temperature, with stronger strains more prevalent at 
lower temperature and weaker strains more prevalent at higher temperature.  Therefore, 
both Sc4/ScS and Sc37/ScP samples produce an array of strain phenotypes, the 
predominant, (but not exclusive), of which are strong and weak, respectively. Non-
homogeneity of each sample apparently originates from the fact that in vitro aggregation 
is initiated by multiple nucleation events in each case. 
 
 
Figure 2.11: In vivo testing study. Transfection experiments are conducted by enzymatically 
stripping the yeasts’ cell walls, then simultaneously transforming a marker plasmid and amyloid 
material. The yeast is then regrown in stabilizing media (A). Classification of strains (B) and 
transfection results (C). Patches from transfection of ScP (D) and ScS (E) are shown to illustrate 
the most divergent phenotype distributions. Data corresponding to the percentages shown in (C) 







Table 2.1: Transfection results. The frequency of [PSI
+
] phenotypes and percent 
transfection efficiency is presented.   
 Perchlorate Nitrate Chloride PBS Sulfate 
Weak [PSI
+
] 11 16 4 3 2 
Intermediate [PSI
+
] 1 47 12 5 9 
Strong [PSI
+
] 3 6 14 15 18 
Total [PSI
+
] colonies 15 69 30 23 29 
Total transformants checked 49 242 150 76 142 




Our data confirm an inverse Hofmeister effect on Sup35NM aggregation, which 
agrees with our previous work 
18
 and with observations for other amyloidogenic proteins 
that allow this conclusion while not explicitly stating it 
43, 44, 46
. An “inverse” Hofmeister 
trend arises when a colloidal particle is positively charged and hydrophilic or when a 
particle is negatively charged and hydrophobic 
56
. We probably observe this trend 
because unfolded proteins are inherently hydrophobic  
57
 and at our operating pH, 7.4, 




Figure 2.12: Determination of Sup35NM’s isoelectric point. 
 
 We hypothesize that the structural and biological differences observed between 
amyloids produced in kosmotropes versus chaotropes stem from their contrasting 
amyloid formation kinetics. Although the theory on why and how Hofmeister effects 
exist is still evolving, the notion that chaotropes adsorb onto the protein surface and 
kosmotropes preferentially interact with bulk water is generally accepted 
56-58
. The 
adsorption of chaotropes to the proteins’ surface changes the proteins’ topography and 
electrostatic landscape and, given that amyloid formation is a site-specific, recognition-
based process 
26-30
, such steric or electrostatic alterations likely hinder aggregation; 
however, these aggregates are characterized by a higher degree of order and more rigid 
structure. Apparently, the more robust amyloids form due to a selection pressure 
requiring more stringent intermolecular interactions to overcome the anti-aggregation 
effect of chaotropic ions. This means that fewer collisions result in an aggregation event 
(Fig. 2.6) and that the aggregates that ultimately do form are compact and stable (Figs. 
2.7 and 2.9). Even though chaotropes produce more compact aggregates, as we 
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hypothesized, their fiber lengths are generally longer than fibers formed in kosmotropes. 
One might have expected the inverse to be true; however, the number of fibers formed in 
kosmotropes is likely larger than the number of fibers formed in chaotropes due to 
differences in frangibility, resulting in shorter fibers. 
For aggregation in the presence of kosmotropes, we hypothesize that depletion 
interactions accelerate aggregation 
59, 60
. Depletion interaction arises when a solute 
molecule (a hydrated kosmotrope in this case) cannot fit between two colloidal particles 
(proteins). The absence or depletion of kosmotrope from the gap between colliding 
particles means that the unbalanced osmotic pressure associated with the solute 
effectively pushes the two particles together. The more hydrated the ion and the higher 
the salt concentration, the greater the range and strength of this effect become (Fig. 2.6). 
As kosmotropes do not alter a protein’s surface but can be depleted from the gap, 
aggregates form faster, and intermolecular bonds need not be as precise and energetically 
favorable as in the case of aggregation in chaotropes. This leads to aggregates that 
nucleate rapidly, elongate quickly (Fig. 2.6), and are less compact and less stable by 
comparison (Figs. 2.7 and 2.9). 
Transfection experiments confirm that amyloids formed in chaotropes and 
kosmotropes indeed produce different [PSI
+
] strains. Both thermostability and 
transfection assays reveal a clear analogy between amyloids produced in different salts 
(this present work) and at different temperatures 
39-41
. As low temperature, strong 
kosmotropes induce amyloids that are poorly thermostable, frangible, and preferentially 
generate the phenotypically strong [PSI
+
] variants upon transfection. The opposite is true 
for amyloids produced in strong chaotropes or at high temperature. As this and previous 
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works have shown 
61, 62
, Sup35NM is able to create a number of distinct fiber types, 
which alludes to fiber conformations as the determinant of strains 
39
.  
We hypothesize that chaotropic anions sterically alter the prion-recognition domain, 
slowing aggregation and forcing the most energetically favorable inter-molecular bonds 
to be selected, and kosmotropes accelerate aggregation through structural forces 
(depletion interactions, crowding). The disparate kinetics gave rise to varied fiber 
morphologies, as observed using TEM and AFM imaging. Thermostability tests showed 
fibers differ biochemically as well; and finally, transfection experiments proved that the 
varied structures induce different strains. To conclude, our work demonstrates that ion 
composition of the solution determines the amyloid formation rate, which in turn has a 
strong bearing on fiber morphology, prion strains, and infectivity. We further corroborate 
the assertion that form and function in regards to prion aggregates are closely associated. 
More generally, this work supports the supposition that environmental conditions are a 
strong driver of prion variants. The rate of fiber formation, whether it is influenced by 
temperature or ion composition, is the salient determinant of aggregate size, 
compactness/order, stability, and infectivity. Our data may be relevant to understanding 
amyloid formation both in vivo (as local gradients of ions exist in living systems) and in 
vitro (e. g. in the preparations of protein- or peptide-based drugs).  
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HOFMEISTER AND PRION STRAIN EFFECTS ON THE CROSS-
SPECIES NUCLEATION OF YEAST PRION 
 
This chapter is a portion of an on-going collaboration between the Chernoff, Bommarius, 
and Behrens groups. Kathryn Bruce and Aditi Sharma will continue this work in the 
future. Their data will be amalgamated with this chapter and submitted for publication. 
 
3.1 Summary 
In Chapter 2, we showed that forming amyloid in strong kosmotrope or chaotrope 
produced predominately strong or weak prion variants, respectively. Recent work by the 
Chernoff group has shown that prion variant strength has a bearing on prion transmission 
between closely related yeast species. In this chapter, we ask whether the different 
variants produced in salts and having Hofmeister salts in solution effects inter-species 
transmission of [PSI
+
]. Pre-formed amyloid was used to seed to monomer from each of 
the three species examined. Consistent with Chapter 2 and Chernoff’s findings, amyloid 
formed in sulfate was more effective in cross-species seeding and behaved as a strong 
prion would; amyloid formed in perchlorate was ineffective or inhibited co-aggregation 
and acted as a weak prion would. The presence of chaotropic anions in the aggregation 
buffer poisoned amyloid propagation; whereas, addition of kosmotropes accelerated 
amyloid formation when a mild species barrier existed.  
 
3.2 Introduction 
Amyloidogenic proteins are associated with a myriad of protein misfolding diseases in 
mammals, such as Alzheimer’s, Parkinson’s, and “mad cow” disease. In fungi and yeast, 
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amyloid proteins control heritable, epigenetic traits.
1, 2
 These proteins, including a 
transmissible subset known as prions, undergo a conformational change in their 
secondary structure to form β-sheet rich conformers (Fig. 3.1).  The misfolded proteins 
then aggregate along their β-sheets through favorable sterics and hydrogen-bonding 






Figure 3.1: Hypothetical conformational change in the scrapies protein from its properly 
folded cellular form to its infectious, β-sheet rich prion form. This image was adapted 
from an image obtained at <http://www.bio.davidson.edu/Courses/Molbio/MolStudents/ 
spring2003/WilsonE/home.prions.html>, accessed on January 27, 2013.  
 
 
 As shown in Figure 2.1 and discussed in Chapters 1 and 2, misfolded proteins 
recruit native protein of the same amino acid sequence into amyloids by altering the 
previously soluble protein’s structure.
3
 A high degree of sequence recognition is required 
between the amyloid fiber end and the soluble monomer for amyloid elongation to occur. 
Protein mutants and prion strains which alter the amyloid templating surface can seed 
analogous proteins from different species that have different (albeit very similar) amino 
acid sequences.
1, 4-6
 For example, both mice and hamsters contain the ‘prion protein’ PrP 
and both proteins have similar (but not the same) sequence. Despite sequence differences, 




 This phenomenon, where prion transmission between species occurs and is 
markedly less efficient than intra-species transmission, is known as the ‘species barrier’ 
(for review see Collinge and Clark (2007)).
4
 A species barrier is said to be “high” if 
transmission efficiency between two species is very low or non-existent; a “low” species 




3.1.1 Mad cow epidemic 
The great significance of the species barrier became apparent during the infamous bovine 
spongiform encephalopathy (BSE or “mad cow” disease)  epidemic in the United 
Kingdom (1985-96).
8
 Incidents of BSE quickly ballooned from a single case in 1985 to 
~3,000 new cases of BSE per month from 1992-93.
8
 Although 180,000 cases were 
confirmed in total, it is estimated that over one million cattle were infected during the 
decade long outbreak.
4, 9
  Along with mass cattle slaughters, import bans on UK-
produced beef, and a severe decline in UK-produced beef prices, the gravest consequence 
of the mad cow outbreak was the serious public health risk. BSE is able to cross the 
species barrier and manifest itself in humans as a variant of Creutzfeldt-Jakob disease 
(vCJD).
1, 4, 10-15
 In all, 24 cases of vCJD in humans were diagnosed in the UK and one in 
France during the epidemic.
1
  
 Although, BSE and vCJD are enormously impactful medicinally and 
economically, little is known about the molecular mechanism of transmission because 
studies involving cattle are exceedingly long and complex, and human studies are 
confined to epidemiological studies. To probe the species barrier, other models, such as 
yeast and transgenic (Tg) mice, have been developed.
7, 16
 This chapter will focus on yeast 
models, although a significant amount of impactful literature is available on Tg mice 
studies (see works by Prusiner and Collinge and references within).





3.1.2 Yeast species barrier models 
Yeast systems are ideal for studying the species barrier because yeast are easily 
genetically manipulated, have relatively short doubling times, and have a variety of 
prion-like proteins and species to choose from. The species barrier between yeast species 
was first identified when researchers attempted to pass the [PSI
+
] trait, determined by 
Sup35p, from Saccharomyces cerevisiae to other yeast species (e.g. Picha methanolica, 
Candida albicans, and Kluyveromyces lactis) that also contained Sup35p.
6, 19, 20
  These 
yeast species are highly divergent and the species barrier between them is considered 
“long-distance.”
21
 The prion domains (PrDs) between S. cerevisiae Sup35p and the other 
species’ Sup35ps were only 30-40% identical, but all Sup35ps were known to form 
amyloids. Co-aggregation of Sup35p from different species was not observed, likely 
because of sequence divergence between the PrDs;
6




 As would be expected, “short distance” species barriers between more closely 
related yeast species show less of a barrier.
21
 In a pair of recent publications, the Chernoff 
group studied the transmission of [PSI
+
] between three very closely related 
Saccharomyces species.
16, 23
 All three yeast species naturally contain Sup35p; however, 
the sequences of Sup35p, especially in the PrD, are slightly different (Fig. 3.2). Amyloid 
efficiently seeds and accelerates aggregation of monomer in solution if the amyloid and 
monomer are of the same species (i.e. homologous seeding). Chernoff found that cross-
species seeding was notably less effective and asymmetric.
16
 That is, for example, [PSI
+
] 
from S. paradoxus (SP) was faithfully transmitted to S. cerevisiae (SC), but a high barrier 
was encountered when SC was the donor and SP the recipient.
16
 This may be due to the 







Figure 3.2: Sequence alignments of Sup35N from S. bayanus (SB), S. cerevisiae (SC), 
and S. paradoxus SP). The percent identity and similarity between: SC and SB are 80 and 
86.4, respectively; SC and SP are 94.3 and 96.7, respectively; SB and SP are 77.6 and 
85.6, respectively. 
 
 As discussed in Chapter 2, polymerizing Sup35NM in different electrolyte 
solutions produces different prion strains. In this chapter, we combine that notion with 
Chen et al.’s
23
 finding that prion strains affect interspecies prion transmission. In this 
chapter we examine how amyloid seeds produced in strongly chaotropic or kosmotropic 
solutions from three closely related yeast species from the Saccharomyces senso stricto 
group affect polymerization kinetics of monomer from each of those three species in 
vitro. We also study how salts in the aggregation buffer effect cross-species aggregation. 
This work is meant to probe how prion strains and salts affect inter-species [PSI
+
] 
transmission in vitro. Future transfection experiments, like those in Chapter 2, will be 
conducted to corroborate these findings in vivo. Plasmid shuffle experiments (as 
published previously
23
) will augment our transfection and in vitro kinetic data. 
  
3.3 Materials and Methods 
 
3.3.1 Sup35NM Expression, Purification, and Polymerization 
Sup35NM from S. cerevisiae (SC), S. bayanus (SB), and S. paradoxus (SP) was 
heterologously produced in HMS174 (pLysS) E.coli (Novagen) using a pET20b-
SUP35NM-(His)6 expression vector as previously published.
24
 Ni-NTA purification was 
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performed as described in Chapter 2. Purified protein was precipitated in 100% methanol 
and stored at -80 ⁰C in 80% methanol.  
To polymerize, Sup35NM was prepped as in Chapter 2 and resuspended in PBS 
(pH 7.4) containing 0.5 M of a sodium salt to a final concentration of 10 μM protein. The 
protein salt solution was rotated at 20 rpm at room temperature for 48 hours then stored at 
-80 ⁰C.  
 
3.3.2 Kinetic Assays 
Solutions of thioflavin T (Sigma Aldrich) were prepared daily in PBS. Aggregation 
experiments were conducted in at least duplicate with final ThT and Sup35NM 
concentrations of 100 μM and 10 μM, respectively, and containing a sodium salt. In non-
seeded experiments, polymerization was initiated by shaking samples at 18 Hz linearly at 
25 ⁰C in a BioTek Instruments Synergy H4 Hybrid Multi-Mode Microplate Reader 
(Winooski, VT). Fluorescent readings were taken every 15 minutes for 16 hours using an 
excitation wavelength of 440 nm and emission wavelength of 480 nm. Data was modeled 
using a non-linear MATLAB sigmoidal curve fitting program (Appendix A).  
 For seeded experiments, seeds were first sonicated then added to monomer at 5% 
(v/v), as previously published.
16
 The ThT kinetic data and modeling were performed as 







3.4 Results and Discussion 
 
3.4.1 Non-Seeded Aggregation Kinetics in High Salt Conditions 
Aggregation kinetics with SC, SB, and SP monomer were run in solutions containing a 
strong kosmotrope (sulfate), a strong chaotrope (perchlorate), a neutral salt (chloride), or 
in PBS with no added salt (Figure 3.3).  Figures 3.3A-C show kinetic runs with SC, SB, 
and SP, respectively, in different salt solutions. Figure 3.3D presents the lag times from 
the kinetic runs in Figures 3.3A-C as determined by the sigmoidal curve model presented 
in Chapter 2. The same trend in ion-specificity was apparent for all three yeast species, 
which agrees with results in Chapter 2 and previously published work on Sup35NMSC.
24
 
For all species, the lag time was shortest in sulfate, longest in perchlorate, and in between 
in chloride. The duration of the lag phase was also salt concentration dependent, with 
added sulfate decreasing the lag time and additional perchlorate increasing the lag time, 
again consistent with Sup35NMSC results in Chapter 2.  
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Figure 3.3: Non-seeded kinetic experiments in sulfate, chloride, and perchlorate for (A) 
SC, (B) SB, and (C) SP. The kinetic curves presented are averages of three experiments 
run in parallel. The averages were normalized to unity. (D) The lag times from each 
kinetic curve were obtained using the kinetic model present in Chapter 2. The color scale 
from green to red aids in visualizing short to long lag.  
 
 Figure 3.3 establishes that ion-specific interactions are the same for Sup35NM 
from all three yeast species. Notably, the duration of the lag time between species 
differed. SC and SB show similar lag times in all salts, but SP has considerably longer lag 
times in all conditions. This is a species specific finding and is in agreement with 
anecdotal, unpublished evidence from the Chernoff group. 
 
3.4.2 Self- and Cross-Seeded Aggregation Kinetics  
Homologous and heterologous kinetic seeding experiments were carried out in PBS 
(Figures 3.4). As expected, seeding a monomer with amyloid from the same species 
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(homologous) was very efficient and accelerated aggregation.
16, 23, 24
 Figure 3.4A presents 
a representative comparison between non-seed and homologously seeded SP monomer. 
Aggregation was initiated in 51 minutes in the seeded case, whereas the non-seeded 
experiment took over 300 minutes to begin aggregating.  
 Similar decreases in lag time were seen for every homologous combination of 
seed and monomer compare to the ‘no seed’ control (Figs. 3.4B-D). Homologous seeding 
using the SC and SB amyloids formed in perchlorate were not as efficient as seeds 
formed sulfate or chloride. Chen et al. (2010) previously showed that weak prion variants 
(such as those formed in perchlorate) from SC are more poorly transmitted to SC in vivo 
than strong variants (such as those formed in sulfate),
23
 which agrees with our results.  
A species barrier was apparent for heterologous seeding experiments; however, 
the barrier’s stringency varied. SP seeds formed in sulfate seeded SC monomer 
effectively; however, all SB seeds slowed or poisoned SC monomer aggregation (Fig. 
3.4B). Amyloid poisoning is a phenomenon where heterologous amyloid poorly 
templates monomer and hinders amyloid propagation. Poisoning can lead to “curing” or 
loss of the prion in vivo (for review on amyloid poisoning see Bruce and Chernoff and 
references within).
21
 SB monomer showed a high species barrier with both SC and SP 
seeds (Fig. 3.4C). SP monomer was seeded well by SC amyloid formed in sulfate, but 
nothing else. SB seeds poisoned SP monomer aggregation (Fig. 3.4D). Poisoning with SB 
seeds may be derived from Sup35NMSB being seven amino acids shorter than 
Sup35NMSC or Sup35NMSP (Fig. 3.2). The shorter protein length may account for why 
SB seeds are an ineffective template heterologously. From our data it is unclear whether 




Figure 3.4: Homologous and heterologous seeding lag times. (A) Comparison between 
SP aggregation kinetics in PBS (not seeded) and SP monomer with SP seed formed in 
perchlorate. Homologous and heterologous seeding lag times for (B) SC monomer, (C) 
SB monomer, and (D) SP monomer are presented. The color scale from green to red is 
the same as in Figure 3.3. NOTE: the species axis is NOT the same for figures B-D; this 
was done to aid in visualizing all data. 
 
To compare seeded to non-seeded aggregation, the change in lag time was 












Lag Chloride    (Eqn. 3.1) 
 
The chloride seeded aggregation experiments were used in this calculation 
because chloride is the most neutral Hofmeister salt and produces amyloid of all strains. 
Negative ΔLag suggests effective seeding and positive ΔLag indicates that seeding 
slowed aggregation. The magnitude of ΔLag describes how high or low the species 
barrier is. Our ΔLag values are generally in agreement with in vivo cytoduction and 
plasmid shuffle experiments performed by Chen et al.
16, 23
 All except one heterologous 
combination of seed and monomer agree with Chen et al.’s (2007) cytoduction 
experiments (Table 3.1). Chen et al. found that SC monomer was seeded well by SB 
polymer,
16
 but our in vitro experiments showed the opposite behavior.  
In 2010, Chen et al. investigated how prion strains affected heterologous seeding 
using SC seeds. Their cytoduction and plasmid shuffle results showed that strong SC 
seeds were effectively transmitted to SC and SP, but not to SB,
23
 just as our SC sulfate 
seeds were. Weak SC seeds were transmitted to SB and SP at notably lower efficiencies 
than strong seeds were. Our results agree with both trends for strong and weak seeds, 






Table 3.1: Comparison between previously published work by Chen et al. and current 
work. The transmission efficiency data is taken from Chen et al..
4
 The change in lag time 
shows the reduction in lag between seed and non-seeded aggregation. 
[PSI+] donor [psi-] recipient 
Transmission 
Efficiency (%) 
Δ Lag Time (%) 
SC SC 100 -100 
SB 2.1 61.2 
SP 13 -4.4 
SB SC 76.7 9.2 
SB 97.5 -100 
SP 6.9 -7.4 
SP SC 95.6 -53.1 
SB 3.8 75.1 
SP 97.5 -67.6 
 
 
3.4.3 Sup35NMSC Amyloid Cross-Species Seeding in High Salt Solutions 
Since fibril formation is recognition dependent process, the presences of chaotropes or 
kosmotropes in a seeded solution may have a bearing on whether a monomer can 
conform to an amyloid template successfully or not. Chaotropes adsorb to both the 
amyloid surface and monomer. The additional surface changes and changes in template 
topography potentially slowing the already slow inter-species transmission. Kosmotropes, 
by the preferential interaction model,
25
 would force amyloid and monomer together and 
accelerate aggregation. In this set of experiments we use seeds from S. cerevisiae and 
monomer from SB or SP (just as we did in section 3.4.3) with 0.4 M of salt added to the 
aggregation solution. These experiments were meant to test if salts had an effect on the 
species barrier. From the section 3.4.2, we observed a high species barrier when SB 
monomer was seeded with SC and a mild barrier when SP monomer was seeded by SC.  
 Seeding the presence of sulfate was the most efficient (Figs. 3.5A, B). The lag 
time observed for SB monomer with SC seeds in sulfate (Fig. 3.5A) was very similar to 
the lag time observed for non-seeded SB monomer in sulfate (Fig. 3.3B). This suggests 
that the high species barrier (ΔLag = 61.2) was not overcome; rather, the strong 
kosmotrope caused the SB monomer to aggregate rapidly on its own. Future experiments 
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could be conducted to ascertain whether co-aggregation was occurring or not. The lag 
times for SP monomer in sulfate were decreased compared to heterologous seeding 
without salt (Fig. 3.5B) or non-seeded SP in sulfate (Fig. 3.3C). This result suggests that 
sulfate aided in overcoming the species barrier. With no salt added, SC seeds could 
template SP, but not very effectively (ΔLag = -4.4). The addition of kosmotrope likely 
forced greater SP monomer - SC seeds interactions, as per the preferential interaction 
model. This theory could be further tested by examining if sulfate increases seeding of SP 
monomer with SB seeds since we see a mild species barrier between that pair (Table 3.1, 
ΔLag = -7.4). 
 The presence of chaotrope in solution poisoned inter-species transmission. The 
large red bars in Figures 3.5 A and B indicate that no aggregation was detected during the 
15 hour experiments. It is possible that aggregation may occur after a longer period of 
time. Perchlorate, and chloride to a lesser extent, greatly slowed or completely inhibited 
aggregation. The high species barrier observed for SB monomer – SC seed systems in 
solutions without salt is exacerbated by the addition of chaotrope. The mild species 
barrier for SP monomer – SC seed systems became high in chaotropic solutions (Fig. 
3.5B). Addition of chaotrope stymied co-aggregation in all combinations tested, 
regardless of the strain of the seed. Strong [PSI
+
] seeds did have lower lag times in 
chaotropic solutions than weak [PSI
+
] seeds, but both were slower than solutions without 
chaotrope.  
 From these data and Figures 3.4, it is apparent that the strain variant of the [PSI
+
] 
donor has an impact on the efficacy of transmission, as was seen in Chen et al. (2010).
23
 
We can also see that salts in solutions do effect inter-species transmission. Kosmotropes 




Figure 3.5: Seeding experiments in 0.4 M salt. SC seeds were used for all experiments. 
(A) SB monomer, (B) SP monomer lag times. The no salt added data is heterologous 
seeding data taken from Figure 3.4. 
 
3.5 Conclusion and Future Work 
This chapter studied the effect of ion-specificity on the species barrier between three 
closely related yeast species. All three species showed the same trend in ion-specificity in 
non-seeded experiments. Homologous seeding experiments for all species were 
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expectedly efficient; however, a species barrier was observed during heterologous 
seeding. As shown in Chapter 2, seeds formed in sulfate are predominantly strong and 
seeds formed in perchlorate are predominately weak. The cross-species transmission of 
[PSI
+
] was strain-dependent, when the barrier could be overcome. Additional 
kosmotropic anions in the seeded aggregation solution accelerated co-aggregation if the 
species barrier was mild. Chaotropic anions poisoned amyloid propagation. These results 
reveal the dichotomous behavior salts have with the species barrier and provide another 
example of how chaotropes and kosmotropes interact inversely with proteins. 
 Future work on this topic will include in vivo tranfection experiments to prove 
more conclusively that the strains formed in vitro are in fact strong for sulfate and weak 
for perchlorate, as indicated in this chapter. Other solution additives could be tested to see 
if the behavior observed is ion-specific or a result of differences in surface tension. The 
crowding effect kosmotropes have on polymer and monomer alike should arise in 
solutions of other osmolytes as well. Sucrose could be added to non-seeded or seeded 
solutions to see if kinetics were similar to sulfate. The poisoning effect chaotropes have 
may be reproduced in solutions containing surfactants (SDS) or other surface tension 
reducing agents. These results should look similar to kinetics with perchlorate. 
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CORRELATING AGGREGATION KINETICS AND STATIONARY 
DIFFUSION IN PROTEIN - SODIUM SALT SYSTEMS OBSERVED 
WITH DYNAMIC LIGHT SCATTERING 
 
The following chapter was adapted from our publication in the Journal of Physical 
Chemistry B 2010, 114 (12) 4383-4387. Adriana San Miguel, Andreas Bommarius, and 
Sven Behrens contributed to this work.  
 
4.1 Abstract 
This chapter compares two manifestations of electrolyte-mediated interaction between 
globular proteins. Salt-induced protein aggregation is studied with dynamic light 
scattering (DLS) in solutions of lysozyme and bovine serum albumin (BSA) containing 
different types of sodium salts. The same types of ions are used in a second series of 
measurement assessing the effect of more dilute electrolytes on protein diffusivity in non-
aggregating protein dispersions. Both aggregation and stable diffusion exhibit strong ion-
specificity along the lines of the Hofmeister series: chaotropic counterions act as the 
strongest coagulants and, in stable protein solutions, lead to the lowest “protein 
interaction parameter”, evaluated as the slope of protein diffusivity versus protein 
concentration. Within this common qualitative trend, lysozyme and BSA solutions show 
marked differences, including the sign of the interaction parameter for most of the tested 
solution compositions. Despite the different nature of lysozyme and BSA, a strong 
correlation is found in both cases between the ion-specific interaction parameter and the 
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proteins’ aggregation tendency as indicated by the salt concentration required for fast 
aggregation. The interaction parameter, available via quick and easy DLS measurements 




Protein stability against aggregation is critically important for both disease markers and 
therapeutic agents. Protein aggregates are associated with neurodegenerative diseases 
such as Alzheimer’s, Huntington’s and Parkinson’s disease among many others.
1, 2
 In 
biotechnology, irreversible protein aggregation is a frequently encountered problem in 
the production, formulation, shipping, and storage of therapeutic proteins. Many 
therapeutic proteins are on the market and hundreds more are in clinical and preclinical 
trials.
3-5
 Proteins that are currently on the market are prescribed to treat conditions such 
as diabetes, hemophilia, melanoma, transplant rejection, and myocardial infarction. 
Aggregation of these proteins is undesirable because it reduces protein efficacy, may 
incite an immune response,
6, 7
 and violates FDA regulations requiring pharmaceutical 
proteins to be stable both physically and chemically for 18-24 months to be salable 
(special dispensations to this rule are made).
8, 9
  
Protein aggregation is strongly dependent on environmental factors such as 
temperature, pH, cosolutes, salt type and concentration.
3
 Protein unfolding, amyloid 
formation,
10
 and even enzyme deactivation
11-14
 have begun to be understood as a function 
of effects manifested through the Hofmeister series. However, the effects of salt type on 




Often therapeutic proteins are solubilized, sterilized, and purified under 
harshly denaturing conditions (6 M GdnHCl, 8 M Urea). Aggregation may be initiated 
under these conditions and can propagate through non-covalent interactions and inter-
protein disulfide bonding,
17
 ultimately limiting biological yield. Understanding protein 
interaction at the onset of aggregation can help determine optimal processing and storage 
conditions so that aggregation losses can be minimized.
18
  
While the analysis of later aggregation stages represents considerable 
challenges,
19
 the rate constant k11 of doublet formation is more easily accessible. This rate 












      (Eqn. 4.1) 
 
where N1 is the number concentration of singlets and N0  the initial number concentration 
of monomers before coagulation takes place. Both thermodynamic and hydrodynamic 
interactions between the proteins influence the coagulation rate constant k11. In the 
approximation of irreversible aggregation between isotropically interacting, spherical 
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    (Eqn. 4.2) 
 
Here a is the protein radius, kBT the thermal energy unit, u(r) is the pair interaction 
energy, and D(r) the separation dependent pair diffusion constant, which takes into 
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account the hydrodynamic drag and rises monotonically
23
 from a zero at contact to the 
limiting value: 
 




      (Eqn. 4.3) 
 
where D0 is the familiar single particle diffusion constant described by the Stokes-






       (Eqn. 4.4) 
 
From Eq. 4.2 it is clear that repulsive particle interactions and hydrodynamic drag 
both contribute to stabilize dispersions against aggregation, but the complex interaction 
between real proteins in solution is not captured nearly well enough by the existing 
models to permit quantitative predictions. Experimentally, k11 can be obtained with 
relative ease using dynamic light scattering (DLS). The initial increase of the protein’s 
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   (Eqn. 4.5)    
       
where rh is defined in analogy to Eq. 4.4 as rh(t) = kBT/ 6πηD0(t), rh(0) is the initial value 
before aggregation sets in, rh,1 and rh,2 are the hydrodynamic radii of a single protein and 
a doublet respectively, and their scattering intensities I1, I2. The scattering intensities in 
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principle depend on the scattering angle through the wave vector q. However, the small 
proteins considered in this study act as point scatterers for the 633 nm laser wavelength 
used (qrh << l); therefore, we may safely approximate I2/2I1 as unity. Using the geometric 
relation rh,2/rh,1 = 1.38 for spheres,
24
 and the measured initial change in size, we can solve 
for the coagulation rate constant k11. After considering these assumptions and 














     (Eqn. 4.6) 
 
Interestingly, the mark of protein-protein interactions can be found not only in the 
time dependence of protein diffusivity in aggregating systems, but also in the 
concentration dependence of protein diffusivity in non-aggregating systems. In stable 
protein solutions, protein-protein interaction leads to a concentration dependence of the 
mutual diffusion coefficient: 
 
2
0( ) [1 ( )]DD c D k c O c        (Eqn. 4.7) 
       
This diffusion coefficient and, by extension, the coefficient kD in the virial 
expansion (Eqn. 4.7) are readily accessible to dynamic light scattering.
25
 The coefficient 
kD, known as the protein – protein interaction parameter,
18
 sums up first-order effects of 
both thermodynamic and hydrodynamic particle-particle interactions in dispersions, with 
hydrodynamic coupling and repulsive thermodynamic interactions both leading to an 
increase in D(c) for the case of spherical particles.
26, 27 
For protein systems, the precise 
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interplay of thermodynamic and hydrodynamic contributions cannot currently be 
predicted, and attempts to disentangle these two contributions  experimentally are fraught 
with difficulty.
18
 In this study, we take a pragmatic, semi-empirical approach to correlate 
the net interaction parameter kD of stable protein solutions with aggregation kinetics in 
unstable solutions of similar ion composition but higher ionic strength, retaining in either 
case, both thermodynamic and hydrodynamic contributions. 
Two model proteins, lysozyme and bovine serum albumin (BSA), were chosen to 
investigate the relative stabilization or destabilization of protein dispersions that arise in 
different electrolyte solutions due to Hofmeister effects
28
 (for a review on the state of 
Hofmeister effects, see Kunz
29
). Lysozyme and BSA were chosen because they have 
been studied extensively and have been established as models for protein-solution and 
protein-protein interactions. Both proteins are readily available at high purity and assume 
a roughly spherical conformation in stable solutions.
18, 30
 
The present study examines ion-specificity of salt-induced protein aggregation. 
Using DLS, diffusion coefficients and aggregation rate constants for both proteins are 
established. The two physical parameters are then related, and we find a strong 
correlation between protein diffusivity in non-aggregating systems (mutual diffusion 
coefficients) and aggregating systems (aggregation rate constants).  This paper presents a 
convenient way of inferring information about medium-specific aggregation tendencies 





4.3 Materials and Methods 
 
4.3.1 Protein Purification and Preparation 
Deionized water was used to prepare all solutions. Lysozyme was obtained from Sigma-
Aldrich (St. Louis, MO; >90% purity) and was dissolved in an aqueous sodium acetate 
(Sigma-Aldrich, >99% purity) and acetic acid (Riedel-de-Haen, 96% purity) buffer of pH 
4.25. The solution was then filtered using a Whatman Anotop 10, 0.02 µm pore size 
filter. Filtration removed larger proteins and any other relevant contaminant detectable by 
electrophoresis or DLS. The true concentration of protein was then determined using a 








Bovine serum albumin, Fraction V was obtained from EMD (Gibbstown, NJ, 
>98% purity) and dissolved in an acetate buffer. The dissolved BSA was then filtered 
using a Pall Acrodisc syringe filter, 0.2um Supor Membrane. The filtered solution was 
subsequently loaded onto a GE Healthcare HiPrep 16/60 Sephacryl High Resolution size 
exclusion chromatography column using an Amersham Pharmacia Biotech AKTA 
explorer FPLC. The proper elution fractions were collected and concentrated using a 30 
kDa MW cut-off Pall JumboSep centrifugal membrane filter. The concentrated solution 
was then filtered with a Whatman Anotop 10, 0.02 µm pore size filter. Purity was 





4.3.2 Electrolyte Buffer Preparation 
All salts used were of > 99% purity, ACS regent grade. Salt solutions were made in 
acetate solutions as described above containing one of the follow: sodium sulfate 
anhydrous (Sigma-Aldrich), sodium formate (Aldrich), sodium phosphate monobasic 
(Sigma-Aldrich), sodium fluoride (BDH), sodium chloride (BDH), sodium bromide 
(Sigma-Aldrich), sodium nitrate (Sigma-Aldrich) or sodium iodide (EMD). The pH was 
then adjusted using either sodium hydroxide or the appropriate acid (e.g. sulfuric acid for 
a sulfate solution). The salt solution was filtered using a Pall Acrodisc syringe filter, 0.2 
µm Supor Membrane. 
 
4.3.3 Mutual Diffusion Coefficient Experiments 
Diffusivity measurements were carried out at 25 °C, pH 4.25
32
 and total ionic strength 0.1 
M, 50 mM arising from the acetate buffer and 50 mM of the salt in question. These 
conditions ensured that the protein was in a globular conformation since the melting point 






Salt solutions were mixed with protein solutions of varying protein concentration 
in a low volume Sarstedt UV-transparent disposable cuvette. The sample was stirred very 
gently to avoid shear-induced aggregation and to homogenize the solution. The protein - 
salt solution was then inserted into a Malvern Zetasizer Nano ZS90 for measurement. 




4.3.4 Aggregation Rate Experiments 
All aggregation rate experiments were performed at 25 °C and with a 100 mM acetate 
background buffer. Lysozyme experiments were performed at pH 4.25.
32
 BSA 
experiments were run at pH 4. The lower pH for BSA was chosen to distance the 
aggregation experiments from BSA’s isoelectric point, 4.7.
35 
Samples were prepared similarly to the mutual diffusion coefficient experiments; 
however, in these experiments a wide range of salt molarities were investigated. Protein - 
salt solutions were prepared in cuvettes, and then quickly inserted into the Zetasizer. The 
change in particle hydrodynamic radius was monitored for at least 60 minutes. 
 
4.4 Results and Discussion 
 
4.4.1 Interaction Parameters 
Figures 4.1A and B show the relative diffusivity of lysozyme and BSA, respectively, in 
stable sodium salt solutions of increasing protein concentrations. The slope of each curve 
represents the interaction parameter kD specific for the given ion and ionic strength. 
Larger kD values are indicative of stronger stabilizing (more repulsive) protein-protein 
interaction. The inferred kD values for chaotropic counterions (dashed lines, open icons) 
vary substantially and generally correlate with the Hofmeister series, with kD decreasing 
with increasingly chaotropic counterions (Table 4.1).  For kosmotropes (solid lines, filled 
icons), kD values are larger by comparison and are uniform for lysozyme; whereas, for 
BSA, they are larger, but are not uniform. For BSA and lysozyme, the results generally 
correlate with the Hofmeister series as evidenced by the progression of increasing kD 
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values as we go from chaotropic to kosmotropic counterions. Sulfate is a notable outlier 
if used at the same molarity as the other ions (not shown). If used at a molarity lower by a 
factor of 2
6
, however, the results for sulfate fit squarely into the small range observed for 
the other kosmotropes for lysozyme, as shown (this relation was also used for BSA). A 
scaling with the inverse sixth power of the counterion valency is familiar from the 
classical Schulze-Hardy rule for the critical coagulation concentration (CCC) of charged 
colloidal particles 
The values of kD for lysozyme are positive, whereas most of the values for BSA 
are negative, implying that at the examined pHs, the protein – protein interactions for 
BSA are attractive, whereas the lysozyme interactions are repulsive
36
 (confirmed by 
comparing Figure 4.3a and b). Despite the difference in sign, the same Hofmeister trend 
is apparent in both cases and it is important to note that propensity to aggregate is 
dictated by relative differences in kD for a given protein. In both cases sulfate had a large 
positive kD, suggesting that it will strongly stabilize either protein at the given conditions. 
This is likely due to sulfate being by far the most kosmotropic counterion used, which 
would be expected to stabilize strongly.  
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Figure 4.1: Plots of normalized relative mutual diffusion coefficient as a function of 
protein concentration. Experiments were run at pH 4.25, T = 25 °C, and I = 0.1 M arising 
to 50% from acetate buffer and 50% from the indicated sodium salt, with the exception of 
sodium sulfate, which was diluted by a factor of 2
6
 compared to the monovalent ions, as 











Classically, kosmotropes are said to promote water structure, whereas chaotropes 
are expected to ‘break water structure’ and interact preferentially with the protein (a more 
precise and current account of salt interactions is presented in Chapter 1).
26
 As a result, 
chaotropes will tend to accumulate at the protein surface while kosmotropes will be 
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concentrated in the water bulk away from the protein. The observed variations between 
different chaotropes may thus be caused by ion-protein interaction of varying strength. 
By the same token, the relative similarity of the kosmotropes for lysozyme may stem 
from their common tendency of being depleted from a zone, the excluded volume, around 
the protein. 
  For a given counterion, the protein-protein interaction depends on the ionic 
strength of the solution, and so does the absolute value of kD. At ionic strengths 
sufficiently high to induce protein aggregation, kD becomes inaccessible to DLS because 
the single protein diffusivity is masked by an ever changing distribution of aggregates. It 
seems plausible, however, that of several stable protein solutions with different salt types 
but similar (valency-adjusted) concentration, the ones with the strongest stabilizing 
interaction should require the largest increase in ionic strength in order to induce 
aggregation. We therefore hypothesize that the relative values of the measured kD are a 
robust (and quick!) predictor for the counterion-specific protein aggregation tendency.  
 
4.4.2 Aggregating Protein Concentration Independence 
Before beginning aggregation experiments, we confirmed that the coagulation rate 
constant k11 was independent of the initial concentration of either protein, N1, for both 
chaotropes and kosmotropes. While this independence would clearly be expected for 
colloidal particles, it is not obvious for proteins which can undergo rapid conformational 
changes upon partial unfolding or denaturing.
37
 Figure 4.2 shows that the k11 for 
lysozyme - chloride systems is the same despite changing the lysozyme concentration, 






Figure 4.2: Coagulation rate constants for lysozyme−NaCl systems using different 
lysozyme concentrations. Icons represent different lysozyme molarities. Within 
experimental uncertainty, the four protein molarities yield essentially the same rate 
constant for a given salt molarity. 
 
4.4.3 Protein Aggregation Kinetics 
Like the diffusivities (Figs. 1), our results for the aggregation rate constant k11 (Fig. 4.3a, 
b) again show marked differences between the chaotropes and relative uniformity 
between the kosmotropes for lysozyme and a general Hofmeister trend for BSA. The 
results follow a clear Hofmeister trend for both proteins, with the most chaotropic ions 
inducing aggregation at the lowest ion strength. The ionic strength required for 
kosmotropes to induce fast aggregation was very similar for lysozyme, ~1.5 M. At lower 
ionic strength, in the slow aggregation regime, even these more kosmotropic solutions for 
lysozyme show a Hofmeister trend for both proteins as BSA does. 
 Table 4.1 summarizes the important findings from the two sets of experiments. To 
compare the effect salts had on aggregation, we needed to establish k11 value that could 
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/s satisfied our condition. We therefore use the ionic strength of salt required to 
achieve “fast” aggregation Is as our measure of long-term stability 
 
 
Figure 4.3: Coagulation rate constant, k11, as a function of ionic strength. (a) Lysozyme 
experiments were run at pH 4.25 and T = 25 ⁰C in a 0.1M sodium acetate buffer (top). (b) 




 The CCC value for certain ions was determined. This value is the salt 
concentration at which additional salt no longer accelerates aggregation. This 
phenomenon can be clearly observed as a plateau in k11 versus salt concentration (Figures 
4.3 a and b). These values are presented in Table 4.1 below. 
 




/s, critical coagulation constants 








Is [M] CCC [M] kD [M
-1





 0.23 - 32 ± 5 0.08 0.4 -232 ± 19 -0.068 
NO3
-
 0.28 0.3 29 ± 2 - - - -0.046 
Br
-
 0.55 - 60 ± 4 0.2 0.8 -193 ± 24 -0.032 
Cl
-
 1.51 1.5 84 ± 8 0.45 1.1 -161 ± 2 -0.007 
 HCO2
-
 - - 81 ± 9 0.61 - -111 ± 22 0.052 
H2PO4
-
 1.55 1.5 111 ± 9 0.76 - -76 ± 13 0.340 
F
-
 - - 89 ± 6 - - - 0.1 
SO4
-2
 1.63 - 105 ± 8 1.36 - 223 ± 22 0.208 
 
4.4.4 Correlating kD and Is 
Figure 4.4a and b show a strong correlation between kD and Is, which is quantified by a 
linear correlation coefficient of R
2 
= 0.93 for lysozyme and R
2 
= 0.92 for BSA. The 
Hofmeister trend is expressed in the fact that both kD and Is increase gradually from the 
highly chaotropic (iodide) to very kosmotropic (sulfate) solutions.  
These plots confirm our hypothesis that protein aggregation can be predicted 
using the interaction parameter of stable solutions at low ionic strength. This correlation 




or even weeks depending on protein and aggregation conditions, as opposed to finding 
the interaction parameter which can be done in less than 30 minutes and can be adapted 









/s. (a) Correlation for 
lysozyme; (b) correlation for BSA. 
 
 83 
The two proteins studied have different functions and size (lysozyme MW= 14.4 
kDa; BSA MW= 67 kDa), and markedly different values for kD, with sulfate solutions 
representing an outlier only in the case of BSA, but not for lysozyme (Fig. 4.1). Despite 
all of these inherent differences, there is, for both proteins, a strong correlation between 
the ion-specific interaction parameter kD and the ionic strength Is required to induce fast 
aggregation with the given type of ion. This insensitivity of the correlation seen in Fig. 
4.4 to differences in protein properties instills confidence in the robustness of predictions 
for aggregation tendencies from DLS data on stable solutions.  
 
4.5 Conclusion 
In this work, we studied the mutual diffusion coefficients and coagulation rate constants 
for lysozyme and BSA in sodium salt systems using dynamic light scattering. For both 
proteins and both experiments, we found stabilizing trends against aggregation akin to the 
Hofmeister series. Chaotropes induced aggregation at lower ionic strengths, had lower 
interaction parameters kD, and exhibited variance between each other; whereas 
kosmotropes required much higher ionic strengths to aggregate, and had larger kD values. 
This work suggests that kD for stable protein systems can be used for quick and easy 
predictions of ion-specific aggregation trends. The observations for sulfate in the BSA 
system unparalleled in the lysozyme system and we do not have a satisfying explanation 
at this point. Nonetheless the correlation works beautifully for two very different proteins 
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SALT-INDUCED AGGREGATION OF A MONOCLONAL HUMAN 
IMMUNOGOBULIN G1 ANTIBODY 
 
This chapter builds on the work done in chapter 4 and was adapted from our work 
published in the Journal of Pharmaceutical Sciences 2013, 102 (2):377-386. Lars Linden, 
Wayne Coco, Andreas Bommarius, and Sven Behrens also contributed to this work. 
 
5.1 Abstract 
Physical stability is critical for any therapeutic protein’s efficacy and economic viability. 
No reliable theory exists to predict stability de novo, and modeling aggregation is 
challenging as this phenomenon can involve orientation effects, unfolding, and the 
rearrangement of non-covalent bonds inter- and intra-molecularly in a complex sequence 
of poorly understood events. Despite this complexity, the simple observation of protein 
concentration-dependent diffusivity in stable, low ionic-strength solutions can provide 
valuable information about a protein’s propensity to aggregate at higher salt 
concentrations and over longer times. We recently verified this notion using two model 
proteins, and others have shown that this strategy may be applicable to antibodies as well.  
Here we expand our previous study to a monoclonal hIgG1 antibody and discuss both 
merits and limitations of stability assessments based on the diffusional virial coefficient 
kD.  We find this parameter to be a good predictor of relative protein stability in solutions 
of different chaotropic salts, and a telling heuristic for the effect of kosmotropes. Both 
temperature and glycosylation are seen to have a strong influence on kD, and we examine 
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how these factors affect stability assessments. Protein unfolding is monitored with a 
fluorescence assay to assist in interpreting the observed aggregation rates.  
 
5.2 Introduction 
Antibodies represent the fastest growing class of human therapeutics.
1,2
 They treat a wide 
range of conditions, including transplant rejection, Non-Hodgkin’s lymphoma, multiple 
sclerosis and a variety of cancers.
1
 As of March 2012, 34 monoclonal antibodies (mAbs) 
were approved for sale in the US and EU, 28 of which are actively marketed and nine of 
the 28 have achieved blockbuster status.
3,4
 
 Irreversible protein aggregation is a common and undesirable occurrence in many 
stages of biopharmaceutical manufacturing including during fermentation, purification, 
formulation, and storage. Aggregates are detrimental because they reduce the efficacy of 
the treatment,
5
 and may elicit an immune response.
6
 Due to these concerns, the ICH has 
regulated that a biological pharmaceutical must have a shelf-life greater than six months 
(>12 months is recommended) under its prescribed storage conditions to be salable (Q5C 
ICH § 4.3 (1995)).
7
 
 The physical stability of antibodies, like that of all proteins, is strongly influenced 
by their solvent conditions (pH, co-solutes, temperature, ionic strength, etc.).
8,9
 Salts play 
a critical role in protein stability as they are used in buffers, stabilizers, acidifiers and as 
tonicity agents in pharmaceutical formulations.
8
 Salts exert both ion-specific 
(Hofmeister) and non-specific effects on proteins; consequently, both the salt 





Often during clinical trials, accelerated tests of protein stability are employed 
using exaggerated conditions (temperature, shaking, ionic strength, light, relative 
humidity, etc.). Even these accelerated studies or “stress” tests often take 3 – 6 months to 
conduct.
8
 In order to restrict the number of conditions to be tested, researchers often look 
to in silico screening techniques
11
 and to physical or thermodynamic properties indicative 
of stability.   
A commonly used indicator of protein physical stability is the osmotic second 
virial coefficient B22.  This thermodynamic parameter measures protein inter-particle 
interactions and is most often used to determine crystallization conditions.
12,13
 Methods 
commonly used to determine B22, such as static light scattering,
14,15
 analytical 
ultracentrifugation, or self-interaction chromatography
16
 are comparatively time 
consuming and thus not well suited for high-throughput analysis.
17-19
   
We previously proposed a fast and convenient technique for evaluating protein 
stability, and successfully applied it to two model proteins.
20
 Our method for predicting 
trends of salt-induced aggregation analyzes the protein diffusivity in stable solutions at 
lower salt concentrations than would be required to actually trigger any appreciable 
aggregation. In these stable samples, we measure the dependence of protein diffusivity on 
the protein concentration and evaluate the protein-protein interaction parameter kD given 
by the linear coefficient in the virial expansion 
 
2
0( ) [1 ( )]DD c D k c O c                  (Eqn. 5.1) 
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where D(c) is the concentration dependent mutual diffusion coefficient conveniently 
accessible by dynamic light scattering in a matter of minutes, D0 is the diffusion 
coefficient at infinite dilution, and c is the molar protein concentration.  The interaction 
parameter kD is related to the osmotic virial coefficient  
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Here NA is Avogadro’s number, a  the protein radius, ( )u r  
the pair interaction energy as 
a function of the center-to-center separation between two proteins, Bk T  
the thermal 
energy unit, 1  the linear coefficient from the virial expansion of the friction coefficient, 
and   the protein’s molar volume.  As Equation 5.3 shows, kD accounts for both the 
thermodynamic protein interaction, reflected in B22, and the hydrodynamic interaction, 
reflected in ζ1. Similarly, both thermodynamic and hydrodynamic interactions generally 
affect aggregation kinetics: the rate constant k11 of aggregation in the initial stages, for 
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Here h(r) is a separation dependent hydrodynamic correction to the bulk diffusion 
coefficient D, and the pair potential u(r) again represents the thermodynamic interaction. 
Equation 5.4 strictly applies to irreversible aggregation between isotropically interacting 
rigid spheres,
22
 whereas proteins are generally non-spherical, non-rigid because of their 
folding/unfolding degrees of freedom, and interact anisotropically because of non-
uniform surface charge distributions. One might nonetheless expect the actual rate of 
protein aggregation to be governed by a similar interplay of thermodynamic and 
hydrodynamic interaction, the same forces that also determine the interaction parameter 
kD (Eqns. 5.2 and 5.3). Experimentally, we have indeed found a very strong correlation 
between kD for stable protein solutions of different salt compositions and the stability 
against aggregation upon further addition of the same salts.
20
  
 The interaction parameter kD can thus indicate relative protein stability in a fast 
assay that does not consume or degrade the protein. Our previous investigation was 
limited, however, to the model proteins lysozyme and BSA.
20
 A recent study by Saluja et 
al.
17
 suggests that the concept may be extended to predict the aggregation behavior of 
monoclonal antibodies and even shows kD to be a more sensitive indicator of aggregation 
propensity than B22 for the investigated systems.  
In this chapter we take a closer look at the limitations of stability assessments 
based on the interaction parameter kD when applied to a pharmaceutically relevant 
monoclonal human immunoglobulin G1 (IgG1) antibody and its aglycosylated 
counterpart. While the relative stability of these antibodies in different chaotropic 
solutions is accurately reflected in measured values of kD, the influence of different 
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kosmotropic media on protein stability cannot be resolved in the same way. We further 
show that caution is warranted when interpreting variations in the interaction parameter 
caused by (de)glycosylation or temperature changes. Lastly, we study the antibodies’ 
folding state during salt-induced aggregation using the hydrophobic residue binding dye 
8-anilino-1-naphthalenesulfonic acid (ANS) and relate the findings to the observed 
aggregate growth.  
  
5.3 Materials and Methods 
 
5.3.1 Antibodies 
A pair of human IgG1 monoclonal antibodies (MW = 145 kDa) was used as the basis for 
this study. The two proteins were a glycosylated and an aglycosylated version of a 
protein with the same amino acid sequence and a pI of 8.23. The aglycosylated version 
was generated by introducing the mutation N297A into the heavy chain as described 
previously.
23
 The purified proteins were provided by Bayer Pharma AG (Germany) in 25 
mM acetate buffer (pH 5.5) and 150 mM sodium chloride. The formulation was purified 
via buffer exchange cross-flow and size-exclusion chromatography, then sterile filtered 
and frozen in liquid nitrogen. The glycosylated IgG1 was present at 362 M (52.3 
mg/mL) and the aglycosylated antibody was provided at 80 M (11.49 mg/mL). The 
concentration of the antibodies was determined prior to experimentation using a molar 
extinction coefficient of 235,480 (M*cm)
-1




5.3.2 Salt Buffer Preparation 
All salts used were of > 99% purity, ACS reagent grade. Salt solutions were prepared in 
the isotonic acetate buffer described above. Solutions  contained one of the following: 
sodium citrate (J.T. Baker)/ citric acid (Sigma-Aldrich), sodium sulfate anhydrous 
(Sigma-Aldrich), sodium acetate (Sigma-Aldrich)/ acetic acid (Riedel-de Haen, purity 
96%), sodium formate (Aldrich), sodium fluoride (BDH), sodium chloride (BDH), 
sodium bromide (Sigma-Aldrich), sodium nitrate (Sigma-Aldrich), sodium iodide 
(EMD), sodium thiocyanate (Sigma-Aldrich). After dissolving salt in the buffer described 
above, the pH was readjusted, if necessary, to 5.5 ± 0.05 using either sodium hydroxide 
or the appropriate acid (i.e., sulfuric acid for a sulfate solution). The salt solution was 
then filtered through a hydrophilic polyethersulfone membrane with 0.2 μm pores (Pall 
Acrodisc® syringe filter with Supor® membrane). 
 
5.3.3 Interaction Parameter Determination 
Diffusivity measurements were carried out at 25, 35 and 45 °C, pH 5.5, and ionic strength 
0.225 M (175 mM arising from the ubiquitous background buffer described above and 50 
mM from the salt being tested). In these conditions the protein remains stable in its native 
conformation (Tms shown in Table 5.2 and Appendix C). 
Prepared salt solutions and protein solutions were mixed in a Corning black-
walled 96-well plate with final protein concentrations between 12 and 180 μM (1.4 and 
26 mg/mL). The samples were stirred very gently to provide adequate mixing while 
avoiding shear-induced aggregation. They were then capped by a layer of silicon oil to 
prevent solvent evaporation and investigated by dynamic light scattering (DLS) using a 
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Wyatt DynaPro plate reader, which operates in a backscattering geometry (158⁰). A set of 
experiments (for reasons described in section 5.4.1) using paraffin or white mineral oil 
instead of silicon to cap wells was also performed. Silicon and paraffin oil had no effect 
on the readings as they are insoluble in water. Every well was read 10 consecutive times 
for 20 second each. Diffusivity readings obtained from DLS measurements at the same 
protein concentration were averaged (e.g. Fig. 5.1).  
 
 
Figure 5.1: Apparent hydrodynamic radius R(c) versus protein concentration as 
measured by dynamic light scattering (DLS) in NaBr at 25
0
C. Extrapolation to zero 
protein concentration yields the actual hydrodynamic protein radius R0. 
 






     (Eqn. 5.5) 
 
where Bk T  is the thermal unit and   is the medium viscosity. We can therefore plot  
y = 0.0081x + 5.2319 
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as shown in Figure 5.2 (D0  is the diffusion coefficient at infinite dilution, found from the 
infinite dilution radius in Fig. 5.1). The interaction parameter kD is obtained as the initial 





Figure 5.2: Normalized diffusion coefficient versus protein concentration. The slope of 
the regression line is the interaction parameter. 
 
5.3.4 Aggregation Rate Experiments 
Aggregation rate experiments were performed at 35 and 45 °C. Samples were prepared in 
96-well plates similarly to the diffusivity experiments; however, in these experiments, a 
wide range of salt molarities were investigated. The hydrodynamic radius of each sample 
was tracked over a minimum of 12 hours (Fig. 5.3). The change in particle hydrodynamic 




y = -0.0012x + 1 
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Figure 5.3: Aggregation of the glycosylated antibody in 0.75 M SCN
-
. The linear 
regression line and equation give the initial radius in nm (y-intercept) and change in 
radius over time in nm/s (slope). 
 
The initial increase of the protein’s hydrodynamic radius Rh at the onset of aggregation 














R dt I q R
  
        
             (Eqn. 5.7)
 
 
where Rh(0) is the initial value before aggregation sets in, Rh,1 and Rh,2 are the 
hydrodynamic radii of a single protein and a doublet, respectively, and I1 and I2 are their 
respective scattering intensities. N1 is the number concentration of singlets in solution. 
The scattering intensities in principle depend on the scattering angle through the wave 
vector q. However, the small proteins considered in this study act as point scatterers for 
the 830 nm laser wavelength used (q Rh << 1); therefore, we may safely approximate 


























I2/2I1 as unity. Using the geometric relation Rh,2/ Rh,1 = 1.38 for spheres,
24
 and the 
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From Eqn. 5.8 we can solve for the coagulation rate constant k11 graphically given that 
we know N1 (the number of monomers we begin the experiment with) by measuring 
dRh(0)/dt via DLS, as in Fig. 5.3.From Figure 5.3 we can obtain Rh(0) [nm] (y-intercept) 
and dRh(0)/dt [nm/s] (slope).  
 
5.3.5 ANS Binding 
A solution of 8-anilino-1-naphthalenesulfonic acid (ANS, Sigma-Aldrich) was prepared 
daily in the acetate buffer described above. Samples were prepared in duplicates in a 
black-walled 96-well plate. All experiments were conducted at 35 ⁰C, the protein 
concentration was 3.5 μM (0.4 mg/mL, for both proteins), and 60 μM ANS was present 
in each well in addition to the salt in question. For every salt, a pair of wells without 
protein, but containing the same concentration of salt and ANS, were run as controls. The 
fully loaded well plate was inserted into a preheated BioTek Instruments Synergy H4 
Hybrid Multi-Mode Microplate Reader. Using an excitation wavelength of 360 nm and 
an emission wavelength of 475 nm, the fluorescence signal in each well was read every 
ten minutes for 12 hours. The background fluorescence obtained from the protein-free 
controls was subtracted from each sample’s fluorescence. The initial slope in the 
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logarithm of the fluorescence signal versus time was interpreted as an apparent initial rate 
of unfolding.  
 
5.3.6 Melting Temperatures 
The antibodies’ melting temperatures were determined using a Jasco J-810 circular 
dichroism (CD) spectrophotometer (Easton, MD) equip with a Peltier temperature 
controller. Experiments were conducted at a protein of 120 μg/ml and ionic strength of 
200 mM of a given salt. A linear 1 ⁰C/minute temperature ramp was run from 30 – 90 ⁰C 
and the change in CD ellipticity at 218 nm (β-sheet) was monitored. The data were then 




5.4.1 Interaction Parameter  
Figure 5.4 shows interaction parameters obtained for the glycosylated and non-
glycosylated hIgG1 respectively, for a range of different salts and three temperatures. 
Salts are organized by their Jones-Dole viscosity B-coefficient (at 25 ⁰C) on the x-axis; 
this allows the reader to easily distinguish between chaotropic (B < 0) and kosmotropic 


























B-value -0.103 -0.068 -0.061 -0.032 -0.007 0.052 0.10 0.208 0.25 
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 Although weak intermolecular interactions, such as reversible dimerization are 
possible at the protein concentrations used and would alter the value of kD, we do not 
observe such phenomena as evidenced by the polydispersity index of 0.1 for most of our 
measurements (the lowest possible reading for our instrument).  
The interaction parameters for the glycosylated antibody (Figure 5.4A) follow a 
clear trend along the lines of the Hofmeister series. This trend gets blurred with 
increasing temperature. The most chaotropic salt investigated (thiocyanate, B = -0.103) 
yields the most negative kD. Less chaotropic salts lead to larger (less negative) values of 
kD. Kosmotropes give kD values similar to each other at all three temperatures and yield 
the least negative kD values.  
Sulfate (B = 0.208) is the only divalent ion in this series of experiments. If tested 
at the same molarity or ionic strength as all the other salts, kD would have been 
considerably lower (not shown). However, if we scale the molarity by a factor of 2
6
 then 
sulfate behaves more similar to the other kosmotropes (Figure 5.4). Such scaling by the 
inverse sixth power of the counterion’s valency is familiar from the classical Schulze-
Hardy rule for the critical coagulation constant (CCC) of charged colloidal particles.
26
  
The non-glycosylated antibody’s kD values (Figure 5.4B) are generally more 
negative than the values for their glycosylated counterpart. As with the glycosylated 
protein, the clearest trend is observed for the non-glycosylated protein at 25 ⁰C. The most 
chaotropic counterions lead to the lowest kD and most kosmotropic counterions to the 
highest. At elevated temperatures (35 and 45 ⁰C), kD does not vary significantly between 
salts, and substantial scatter makes it difficult to discern any systematic trend.  
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Figure 5.4: Interaction parameters for glycosylated (A) and non-glycosylated (B) IgG1 at 
25°C (□), 35° (∆), and 45°C (○). Error for kD at 25 ⁰C is presented in Table 5.2. 
 
To ensure that the silicon oil was not affecting our kD measurements, we 
performed kD experiments with the non-glycosylated protein using paraffin oil (Fig. 5.5) 
or white mineral oil (not shown) as the capping oil. The use of paraffin or silicon oil to 
cap wells produced generally similar results with respect to the Hofmeister trend 
observed at 25 ⁰C and lack thereof at higher temperatures; either oil is suitable for this 
application. The results from experiments with white mineral oil are not shown because 
of significant scatter; we do not recommend using white mineral oil for this application. 
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Figure 5.5: Interaction parameters for the aglycosylated protein at 25 ⁰C (□), 35 ⁰C (∆), 
and 45 ⁰C (o) using paraffin oil to prevent solvent evaporation.  
 
While plots of the normalized diffusion coefficient D(c)/D0 as in Fig. 5.4 are 
useful because they directly yield kD, this representation does not allow to judge the 
absolute magnitude of the diffusion coefficient. In Fig. 5.6 we have therefore also plotted 
the absolute diffusion coefficient D0 used for the normalization and obtained by 
extrapolating the measured diffusivities to zero antibody concentration. In this limit, the 
diffusivity should not be affected by specific, ion-mediated protein-protein interaction, 
and Fig. 5.6 confirms that D0 does not depend on the type of salt ion present but only on 
temperature, as one should expect. The values for both the glycosylated and 
aglycosylated antibody are approximately the same, as one would expect since the two 
proteins are macroscopically the same [only differing in their glycosylation patterns]. 
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Figure 5.6: Infinite dilution diffusivities for the glycosylated (top) and aglycosylated 
(bottom) IgG1 at 25 ⁰C (□), 35 ⁰C (Δ), and 45 ⁰C (o). 
 
5.4.2 Aggregation Kinetics 
Elevated salt concentrations were employed to induce aggregation of our IgG1 
antibodies, and the salt-dependent aggregation rates were measured using DLS. Little to 
no aggregation was observed for most salts at 25⁰C over 24 hours (not shown). However, 
aggregation could be detected more easily and in a shorter time frame (12 hours) at 35⁰C; 
these data are presented in Figure 5.7. Accelerating aggregation by means of increasing 
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temperature is a common method for fast assessments of long-term stability.
8,27
 
Aggregation experiments at 45⁰C were also conducted (Fig. 5.8).  
 
Figure 5.7: Coagulation rate constants as function of ionic strength at 35°C for 
thiocyanate (■), iodide (▲), perchlorate (pentagon), bromide (●), and chloride (▼). 
Closed icons are for the glycosylated antibody and open icons are for aglycosylated. 
Fitting error bars (not shown) generated by Excel Linest were on the order of or smaller 
than the data point icons.   
 
In the 25 mM acetate background buffer at 35⁰C, the glycosylated protein did not 
aggregate over 12 hours; however, the aglycosylated antibody aggregated over 12 hours 




/s. At 45⁰C, the rate constants of aggregation for the 








Figure 5.7 shows the aggregation rate constant k11 of both antibodies in solutions 
of different chaotropes. As with the interaction parameter, we see a Hofmeister trend 
where k11 at constant ionic strength generally increased with increasing chaotropicity. 
Thiocyanate caused aggregation at the lowest ionic strength (~1 M), and weaker 
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chaotropes, such as bromide and chloride, required much higher salt concentrations (~4 
M) to destabilize the protein. Surprisingly, glycosylation did not systematically affect the 
aggregation rates (Fig. 5.7): in the presence of very strong chaotropes (thiocyanate, 
iodide, and perchlorate) no significant differences between the aggregation rates of 
glycosylated and aglycosylated antibodies are observed at all, whereas for the weak 
chaotrope bromide glycosylation does appear to provide some stabilization. This effect, 
however, is significant only at ionic strengths (below 4 M NaBr) where aggregation is 




/s).   
Complementing the reported aggregation data at 35⁰C, Figure 5.8 shows 
aggregation rate constants measured at 45⁰C. Aggregation rates were roughly an order of 
magnitude faster at 45 ⁰C versus 35⁰C, but still showed the same Hofmeister trend.  
              
           
Figure 5.8: Coagulation rate constants as function of ionic strength at 45°C for the 
chaotropic anions thiocyanate (■), iodide (▲), bromide (●), and chloride (▼). Solid 




Aggregation experiments with kosmotropes are summarized in Figure 5.9. Unlike 
experiments with chaotropes, they did not show a simple increase in k11 with increasing 
kosmotropicity. Instead, three regimes were apparent: (1) no observable aggregation, (2) 
slow aggregation, and (3) rapid aggregation with almost instantaneous precipitation. 





showed no systematic trend. Regime (3) aggregated too fast to measure. Interestingly, for 
acetate and formate, moderate salt concentrations did not induce any aggregation (regime 
(1)). With acetate, precipitation or gelation of either antibody (i.e. regime (3)) could not 
be achieved in the entire ionic strength range (up to 3.75 M).  
 
 
Figure 5.9: Molarities of a given kosmotropes to induce no aggregation (dotted), slow 






) or instantaneous aggregation (black) for 
glycosylated (“Glyc”) and aglycosylated (“Aglyc”) antibodies. 
 
To aid stability comparisons in the chaotropic solutions, we adopt as a metric for 
the stability against salt-induced aggregation the ionic strength Is required to trigger 






. This same reference value of k11 was 
previously used in our study of lysozyme and BSA in Chapter 4.
28
 The results for Is, 
along with the values of the interaction parameter kD, are reported in Table 5.2. 
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/s), and CD determined melting temperatures (± 1 ⁰C). Two Tms are reported 
because IgGs exhibit two-stage melting behavior corresponding to the melting of the Fc 
and Fab domains. CD melts are presented in Appendix C. The error reported for kD is the 
















0.65 -1465 ± 75 - 0.71 -2233 ± 192 - 
I
-
 1.21 -1387 ± 54 - 1.19 -2125 ± 245 - 
ClO4
- 
0.72 -1436 ± 143 66/77 0.76 -2310 ± 155 66/78 
Br
- 
3.99 -1164 ± 76 - 4.18 -1973 ± 171 - 
Cl
- 
N/A -1113 ± 31 69/79 3.96 -1796 ± 154 68/76 
HCO2
- 
N/A -1115 ± 81 - N/A -1941 ± 134 - 
F
- 
- -1157 ± 21 - - -1665 ± 153 - 
SO4
2- 
N/A -1143 ± 44 73/80 N/A -1737 ± 332 70/78 
CH3CHO2
- 
N/A -1109 ± 30 - N/A -1450 ± 248 - 
 
5.4.3 Correlating kD and Is 
Figure 5.10 presents the correlation between the ionic strength Is inducing aggregation at 






 and the protein – protein interaction parameter kD. Only data for 
the chaotropic counterions are plotted, for reasons discussed earlier.    
 A strong correlation is found for the glycosylated protein (R
2
 = 0.99) and a fair 
correlation for the aglycosylated protein (R
2
 = 0.82). The lower R
2
 for the aglycosylated 








/s for thiocyanate (■), 
iodide (▲), perchlorate (pentagon), bromide (●), and chloride (▼) to their respective 
interaction parameters with fitting error bars shown. Closed icons are for the glycosylated 
antibody and open icons are for the aglycosylated form.  
 
5.4.4 Unfolding and Aggregation 
In chaotropic solutions, increasing salt concentrations always led to faster aggregation 
(Fig. 5.7); in kosmotropic solutions (Fig. 5.9), however, the same was not always true. In 
acetate and formate, both antibodies aggregated slowly at low salt concentrations, but at 
moderate concentrations no aggregation was observed. We suspected that the antibodies’ 
folding state had a strong bearing on this behavior and conducted ANS binding 
experiments to examine the role of unfolding in the aggregation process. 
ANS is a dye which becomes strongly fluorescent upon binding to exposed 
hydrophobic residues. The more unfolded a protein is, the more ANS binds to it and 
enhances the fluorescence intensity.
29
 By monitoring the fluorescence signal we 
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determined the extent of unfolding at the beginning of data acquisition (t = 0) and the rate 
of unfolding at this time in aggregating samples.  
Figures 5.11A and B show the rate of protein unfolding (ANS binding) and initial 
extent of unfolded states in chaotropes, respectively. Chaotropes cause a rapid rate of 
unfolding/ denaturation (Fig. 5.11A) and significant immediate unfolding upon addition 
of salt (Fig. 5.11B). The ionic strength at which the unfolding rate in a solution of a given 
salt becomes non-zero roughly matches our DLS results for the ionic strength at which 
we could first detect aggregation (Figure 5.7).  Further, as one can see in the k11 curves 
(Figure 5.7), a ‘kink’ was found for chloride and bromide; these kinks are also present in 
our ANS experiments (Figure 5.11A) at the same ionic strengths (for chloride and 
bromide between 3.2 – 3.7 M and 3.6 – 4.2 M, respectively).    
Figure 5.11B demonstrates that some salt concentrations induced significant 
immediate unfolding, such as thiocyanate above 1.5 M. For the thiocyanate 
concentrations above 1.5 M, for example, aggregates were visible to the eye within 
seconds, indicating that a high degree of unfolding leads to almost instantaneous 
aggregation. Bromide and chloride above 2.5 M also begin to show some degree of 




Figures 5.11: ANS binding rates for chaotropes (A) and kosmotropes (C); fitting error 
bars generated by Excel Linest were on the order of or smaller than the data point icons. 
Initial ANS binding is displayed for chaotropes (B) and kosmotropes (D); error shown is 
± SD. Chaotropes (A, B) include thiocyanate (■), bromide (●), and chloride (▼). 
Kosmotropes (C, D) include formate (♦), acetate (▲) and sulfate (hexagon). Closed icons 
are for the glycosylated and open icons are for aglycosylated antibody.  
 
Figures 5.11C and D describe the rate of ANS binding and initial ANS binding 
(t= 0), respectively, for both antibodies in the presence of kosmotropes. Sulfate stabilizes 
the folded structure below an ionic strength of 1.5 M, beyond which we see the initial 
unfolding rate  become non-zero; at I = 2 - 3 M the rate of binding decreased over time, 
and beyond 3 M instantaneous precipitation occurred. The decrease in ANS binding at 
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I=2-3 M is likely an effect of the protein equilibrating with the sulfate solution and 
refolding over time; thus reducing ANS binding.  
In the presence of acetate or formate, the rate of unfolding for both proteins is 
zero (Fig. 5.11C) and both proteins are in their native conformation (Fig. 5.11D) up to 1.5 
M salt. At 2 M salt, both antibodies show some degree of unfolding (Fig. 5.11D), yet the 
rate of unfolding is zero (Fig. 5.11C). It is likely that the rate of the slight unfolding in 
this instance is too rapid to measure. This result indicates that despite modest unfolding, 
the antibodies are still stable. This stable, slightly unfolded conformation helps explain 
why at moderate concentrations of acetate and formate no aggregation is observed 
(Figure 5.9).   
 Glycosylation is seen to have a small stabilizing effect on the folding structure in 
chloride, bromide and sulfate solutions. Acetate and formate solutions were generally 
stable, therefore, no significant difference in stability was observed due to glycosylation. 
 From these experiments we find that substantial aggregation and substantial 
unfolding always go hand in hand. In the case of formate and acetate, however, slow 
aggregation is found without significant unfolding (below 1.5M) and slight unfolding 




5.5.1 Manifestation of Hofmeister Effects  
In all three sets of experiments (interaction parameter, salt-induced aggregation, and 
unfolding state experiments), a common trend along the lines of the Hofmeister series 
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was observed. Chaotropes introduced instability, the extent of which depended on the 
chaotropicity of the anion. Kosmotropes stabilized the antibodies; however, the effect of 
different kosmotropes did not vary greatly. This Hofmeister trend, where chaotropes vary 
significantly, but kosmotropes do not, has been observed previously in the case of 
lysozyme’s propensity to aggregate
20
 and the kinetic destabilization of horse liver alcohol 
dehydrogenase, α-chymotrypsin, and mRFP activity.
30
 
This phenomenon can be rationalized by chaotropes’ natural tendency to 
accumulate at the protein surface while kosmotropes act around the protein. Weakly 
hydrated chaotropes adsorb onto hydrophobic surfaces or interfaces (such as air-water 
interfaces or hydrocarbons on proteins).
31,32
 The more chaotropic the ion, the stronger this 
effect and more tightly the ion will bind to a protein
33
 and in turn the greater the observed 
effect. 
The lack of difference between the effects of kosmotropes can be attributed to 
their indirect effect on protein. Kosmotropes are strongly hydrated ions, meaning they 
interact preferentially with water and not with the proteins’ surface.  
Aggregation in presence of sulfate and formate showed a three-stage behavior; 
precipitation did not occur in acetate (see Table 5.1). At moderate salt concentrations for 
acetate and formate (regime 1), both antibodies were well stabilized. Although the DLS 
data showed no aggregation, ANS experiments revealed that some degree of unfolding 
occurred (Fig 5.11D). The slightly unfolded state was stable, as the rate of unfolding was 
zero (Fig 5.11C).  This type of behavior is reminiscent of salting-in behavior. Although 
kosmotropes are classically known as salting-out agents, the phenomena of kosmotropic 
anions at low concentrations salting-in at a pH below the isoelectric point is well known 
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as the “reverse” Hofmeister series (in this case pH = 5.5, pI = 8.23).
34,35
 The origin of this 
behavior is not well established, but it has been argued that that the strongly hydrated 




In all, we found acetate, the strongest kosmotrope tested, to be the most 
stabilizing anion. Additionally, it provides the benefit of excellent buffering properties.  
 
5.5.2 Temperature Effects 
Temperature was varied in both the aggregation rate and interaction parameter 
experiments. As one might expect, increasing temperature accelerated aggregation; 
aggregation rates at 45 ⁰C were greater for all salts than those at 35 ⁰C. As the 
temperature was raised from 25 ⁰C to 45 ⁰C the difference between kD values of different 
anions decreased significantly, rendering kD a less sensitive indicator of ion-specific 
interactions.  
The kD values also became less negative with increasing temperature. From our 
studies on lysozyme and BSA, we observed that larger kD values were strongly correlated 
with increased stability when comparing solution of identical ionic strength and 
temperature, but different ionic composition.
20
 From our current study, we see that 
stability variations with changing temperature at a fixed solution composition cannot be 
inferred in the same way from the interaction parameter. A temperature increase and the 
ensuing viscosity decrease significantly raise the overall magnitude of the diffusion 
coefficient, rendering relative variations due to protein interactions less significant and 
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thus reducing the magnitude of kD and its sensitivity to the medium composition. We 
therefore recommend determining the interaction parameter at 25 ⁰C.  
 
5.5.3 Glycosylation 
 Although glycosylation is well known for its stabilizing effect
37
, this study only 
revealed few instances in which the behavior of the glycosylated and aglycosylated 
antibody differed systematically, and usually these differences were not very pronounced. 
The observable most sensitive to glycosylation was the interaction parameter kD, as can 
be appreciated by comparing the scales of Figures 5.4A and B. Aggregation rates (Figure 
5.7), by contrast, were not affected nearly as much (and not at all in the presence of 
strong chaotropes).  
We may rationalize why kD appears generally more sensitive to glycosylation than 
k11 by considering their dependence on the interaction energy profile u(r) illustrated in 
Figure 5.12. While the aggregation rate k11, according to Eq. 5.4, is governed by the 
maximum (barrier height) in u(r), the interaction parameter kD (Eqs. 5.2 and 5.3) is most 
sensitive to the depth of the primary energy minimum reached upon contact. Modulations 
of the protein-protein interaction that affect both energy extrema should alter both kD and 
k11, but the very short-ranged steric interaction due to oligosaccharides, may change the 





Figure 5.12: Pair interaction potential profile 
 
We nonetheless note that glycosylation does lower the rate of aggregation in the 
presence of bromide in a regime below 4 M (Figure 5.7) where glycosylation also 
appears to reduce the rate and extent of unfolding according to the ANS experiments 
(Figure 5.11). Finally, in the presence of chloride, the aglycosylated antibody showed a 
nonzero unfolding rate at high ionic strength (Figure 5.11A) and achieved aggregation 




/s, whereas the glycosylated antibody did neither.  
 
5.6 Conclusion 
Previously, the “protein interaction parameter” kD accessible by DLS was shown to be a 
fast and reliable predictor for the ion-specific destabilization of globular model proteins 
by different sodium salts.
20
 This work extends the study to the ion-induced destabilization 
of a monoclonal human IgG1 antibody, with regard to both the aggregation and folding 
state of the antibody, and additionally examines the influence of temperature and 
glycosylation. In agreement with our previous work, this work shows that a significantly 
lower kD for one electrolyte composition over another at the same ionic strength is 
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suggestive of lower relative stability. The interaction parameter kD was best determined at 
room temperature (25 ⁰C) as higher temperatures obscured Hofmeister effects. This 
interaction parameter was found to be a good predictor of ion specific aggregation trends 
in the chaotropic regime and a telling heuristic in kosmotropic solutions. We found kD to 
be very sensitive to glycosylation. Despite the strong influence of both temperature and 
glycosylation on kD, these effects do not correlate with stability.  
 Accelerated tests of protein stability are a critical part of bringing a drug to market 
quickly. We have shown that, when interpreted with caution, the interaction parameter 
for stable protein solutions can offer valuable clues about the relative stability in much 
more saline, aggregating conditions. The required diffusivity data are accessible fast and 
without sample degradation by a non-invasive, high-throughput technique, making the 
analysis of interaction parameters a highly promising tool for faster and more directed 
screening of therapeutic proteins.  
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GAUGING COLLOIDAL AND THERMAL STABILITY IN HUMAN 
IGG1 – SUGAR SOLUTIONS THROUGH DIFFUSIVITY 
MEASUREMENTS 
 
This work was submitted for publication in February 2013 under the same title. Lars 
Linden, Andreas Bommarius, and Sven Behrens will be authors on this publication as 
well. 
6.1 Abstract  
Monoclonal antibodies are the fastest growing class of biotherapeutics. Ensuring their 
colloidal stability in liquid dispersions is crucial for maintaining therapeutic efficacy and 
economic viability. Sugars are often added to increase the colloidal and thermal stability 
of protein; yet, determining which sugar is the most stabilizing requires time and sample-
consuming stability tests. Here we show that the extent of stabilization by different sugars 
can be gauged by analyzing the proteins’ diffusive virial coefficient kD. This protein 
interaction parameter is measured conveniently in a non-invasive, high-throughput 
manner using dynamic light scattering. It is found to correlate closely with experimental 
dimerization rate constants and melting temperatures for antibodies in different sugar 
solutions. The proposed analysis thus provides a rapid test of the subtle differences 
between inherently similar sugar-protein interactions; it should greatly facilitate the 






Monoclonal antibodies (mAbs) and antibody-derivatives constitute the fastest 
growing class of biopharmaceuticals.
1
 Antibodies are effective in treating a wide range of 
cancers, autoimmune diseases, inflammation, and potentially even amyloid diseases, such 
as Alzheimer’s.
1-3
 As of March 2012, 28 mAbs were actively marketed in the United 
States and/or the European Union.
4
 The combined sale of the top ten grossing antibodies 
in 2011 was 52.2 billion USD and the commercial market for mAbs is expected to 
continue to grow rapidly.
5
 Six of the top ten selling drugs in 2013 are predicted to be 
mAbs and nearly 350 antibody-derived therapeutics are currently in development.
5, 6
  
Although great advances in antibody engineering have brought many successes to 
market,
7
 the field of biologics still struggles with pervasive physical protein instability 
(for review see Ref.
2, 8
). Irreversible protein aggregation is a familiar and adverse 
occurrence during the fermentation, purification, formulation, and storage of 
biopharmaceuticals, such as antibodies. Aggregates are detrimental because they reduce 
the therapy’s efficacy, are aesthetically undesirable, and, most importantly, may incite an 
immunogenic response within the patient.
9-11
 To avoid these issues, the International 
Conference on Harmonization and FDA have regulated that a biopharmaceutical must 
have a shelf-life greater than six months (>12 months is recommended) under 
manufacturer prescribed storage conditions to be salable [Q5C ICH § 4.3 (1995)]. 
To comply with governmental regulations, researchers work to optimize the 
storage solution environment of mAbs by toggling solution parameters such as the pH, 
 121 
temperature, viscosity, and excipients (salts, sugars, surfactants), to name a few.
12
 Sugars 
are common protein structure stabilizers added to liquid formulations and used to 
stabilize proteins during lyophilization.
2, 8, 13-15
  
 According to the preferential interaction model proposed by Arakawa and 
Timasheff (1982)
13, 16-18
 the stabilization of protein solutions by sugar is caused by the 
preferential hydration of proteins and exclusion of sugar from the protein – water 
interface. Sugars, having many hydrogen bonding sites, preferentially interact with each 
other and with the bulk water, rather than with more hydrophobic molecules (i.e. 
proteins). The sugars’ preference for staying in the bulk solution creates an excluded 
volume of pure water around protein, and elevates interfacial tension. Following the Le 
Chatelier’s principle, such a system will minimize the water–protein interfacial area to 
curtail the thermodynamically unfavorable solvent–protein interactions. As a 
consequence, protein is forced into its most compact conformation: the native state.
17
  
Sugars are also employed during lyophilization to prevent cold denaturation of 
protein.
19
 As temperature decreases rapidly, sugars become vitrified and create a rigid, 
glassy matrix. Proteins are evenly dispersed throughout the sugar matrix and their 
conformational mobility is severely restricted, thus preventing aggregation.
20-22
 An 
extensive network of hydrogen bonds between the vitrified sugar and dispersed proteins 
is thought to maintain the native state.
23
 
To expedite the formulation process, accelerated stability tests are often 
conducted at elevated temperatures (30 ⁰C +); however, these “stress” tests take days to 
months to conduct and are resource intensive.
2, 24
 To minimize a priori the number of 
formulations to be tested, researchers look to in silico behavior
25, 26
 or thermodynamic 
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properties, such as Tg or the second osmotic virial coefficient B22, to gauge stability 
before embarking on lengthy stress tests.
8, 12, 15, 27
 Although these measures are useful, 
none of them are broadly applicable, robust, convenient, and/or fast enough to be 
effective high-throughput screens of stability.
28-30
  
We previously proposed a convenient, high-throughput technique for determining 
within minutes the relative differences in the long-term stability of protein solutions with 
different salt compostition.
29, 31
 This technique uses rapid dynamic light scattering (DLS) 
measurements to evaluate the protein – protein interaction parameter kD in stable 
dispersions. This interaction parameter is the linear coefficient in the virial expansion of 
the proteins’ mutual diffusion coefficient, 
2
0( ) [1 ( )]DD c D k c O c   ,    (Eqn. 6.1) 
where D0 is the diffusion coefficient at infinite dilution, and c is the molar protein 
concentration. kD is related to the familiar osmotic second virial coefficient B22 via
32
  
22 12 ( 2 )Dk B     ,     (Eqn. 6.2) 
where 1  is the linear coefficient from the virial expansion of the friction coefficient, and 
  is the protein’s molar volume. The thermodynamic (B22) and hydrodynamic (ζ1) 
protein-protein interaction that affect protein diffusivity also govern protein aggregation. 
In the initial stages, aggregation kinetics is characterized the rate constant k11 of dimer 
formation, which can be expressed, in the idealized case of isotropic interaction between 























.    (Eqn. 6.3) 
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Here, kBT is a thermal energy unit, the pair interaction energy u(r) reflects the 
thermodynamic interaction, and h(r) is a separation-dependent hydrodynamic correction 
to the bulk diffusion coefficient D. We have demonstrated a close connection between 
experimental values of the  aggregation rate constant and the interaction parameter for 
model proteins
29
 and a pair of human IgG1 antibodies in a variety of salt solutions, and 
pointed out both merits and some limitations
31
 of using kD to infer protein stability. Other 
research groups have also found kD to be an apropos and telling indicator of stability for 
both mAbs and model proteins in saline solutions.
30, 34, 35
  
 The utility of kD is not limited to estimating protein stability in salt solutions. The 
Kalonia and Gokarn groups have shown that kD, determined in low protein 
concentrations, is a good predictor of mAb stability in highly concentrated, viscous 
formulations;
36-38
 Mirarefi and Zukoski used kD to find crystallization conditions for 
lysozyme;
39
 and James and McManus have shown that kD is a good measure of thermal 
and colloidal stability for lysozyme – sugar solutions at different pH.
40
  
In the present work, we investigate the stabilizing effect of sugars on an 
aglycosylated human IgG1 antibody using kD. Although glycosylated mAbs are more 
commonplace, aglycosylated mAbs are easier, cheaper, and faster to produce; as a result, 
they are gaining more attention (for review on aglycosylated mAbs see
41
). Aglycosylated 
mAbs are, in some respects, less stable than their glycosylated counterparts, therefore 
greater attention much be paid to ensure their colloidal and thermal stability as they enter 
later clinical trials.
31, 41-44
 To quantify colloidal and thermal stability we use the (inverse 
of the) dimerization rate constant k11 and the apparent melting temperature Tm,app found 
though circular dichroism (CD), respectively. All of the sugars investigated improve the 
 124 
colloidal and thermal stability of our antibody. We find good correlations between kD and 
both of our stability measures across the collection of sugars tested.  
 
6.3 Materials and Methods 
6.3.1 Antibody Characteristics and Purification 
An aglycosylated human immunoglobulin G1 (hIgG1) antibody with a molecular weight 
of 145 kDa and isoelectric point of 8.23 was used as the basis of this study. The antibody 
contained a N297A mutation in the heavy chain to eliminate glycosylation on that 
asparagine residue, as described previously.
45
 Bayer Pharma AG (Berlin, Germany) 
provided the purified protein at 11.49 mg/mL (80µM) in a pH 5.5 buffer containing 25 
mM acetate and 150 mM sodium chloride. Purification was performed via size-exclusion 
and buffer exchange cross-flow chromatography. The protein was then sterile filtrated 
and frozen in liquid nitrogen. Prior to experimentation, the protein concentration was 






6.3.2 Sugar Solution Preparation 
All saccharides used were ≥98% purity, unless otherwise stated. Stock sugar solutions 
were prepared in the isotonic acetate buffer described above. Solutions contained one of 
the following excipients: D-(-)-fructose, D-(+)-glucose, D-mannitol, D-maltose 
monohydrate (90%, impurities are glucose and maltotriose), D-(+)-trehalose (Sigma-
Aldrich, St. Louis, MS), sucrose (MP Biomedical Inc., Santa Ana, CA), D-sorbitol, or 
xylitol (Alfa Aesar, Ward Hill, MA). None of the sugars caused the pH to deviate more 
than 0.05 pH units from 5.5, so no additional pH adjustment was necessary. The sugar 
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solutions were sterile filtered through a 0.2 μm PallAcrodisc syringe filter with Supor 
membrane (Pall Corporation, Port Washington, NY). 
 
6.3.3 Interaction Parameter Evaluation 
Concentration dependent diffusivity measurements were conducted at 25 ⁰C in the 
aforementioned buffer (25 mM acetate, 150 mM sodium chloride, pH 5.5). Samples 
contained a final concentration of 100 mM of a given sugar. Under these conditions the 
antibody remains stable in its native conformation for over 24 hours (i.e. no change in 
hydrodynamic radius). Prepared sugar solutions were mixed in Corning black-walled 96-
well plates with a final protein concentrations ranging from 1.49 to 10.34 mg/mL (9.24 to 
71.31 µM). Samples were gently mixed, then capped by a layer of silicon oil to prevent 
solvent evaporation. Silicon oil has been shown to have no effect on interaction 
parameter measurements or aggregation in quiescent systems.
31, 46
 Samples were 
investigated by DLS using a Wyatt DynaPro plate reader instrument (Santa Barbara, CA) 
to measure protein diffusivity/size. The instrument operates in backscatter geometry 
(158⁰) using the 830 nm wavelength illumination from a GaAs laser. Each sample well 
was read 10 consecutive times for 30 seconds each. The diffusivity readings were 
averaged then normalized by the diffusivity at infinite dilution. The interaction parameter 
kD was determined as the slope of normalized diffusivity versus protein concentration. An 





6.3.4 Dimerization Rate Experiments 
Aggregation experiments were performed at 5.1 mg/mL antibody at 45 ⁰C. Each sample 
contained 500 mM of a given sugar. The refractive index and viscosity of each sugar 
solution was determined as described and tabulated in the Supporting Information. The 
antibodies were monomeric and natively folded at the beginning of each experiment, as 
evidenced by a low initial polydispersity index [coefficients of variation below 0.1 
obtained via cumulant fit of the intensity autocorrelation function in DLS], uniform initial 
radii in all sugar solutions, and melting temperatures well above 45 ⁰C. Samples were 
prepared in 96-well plates similar to the diffusion experiments. The hydrodynamic radius 
of each sample was tracked continuously over at least 65 hours. The change in protein 
hydrodynamic radius over time was monitored and used to calculate the initial 
aggregation rate constant k11. A sample calculation is presented in the Chapter 5. 
 
6.3.5 Circular Dichroism Melts 
The antibody’s melting temperature was determined using a Jasco J-810 circular 
dichroism spectrophotometer (Easton, Maryland) equipped with a Peltier temperature 
controller. Experiments were conducted at a protein concentration of 120 μg/mL. The 
same sugar concentration (500 mM) was used for this set as in the aggregation rate 
measurements. A linear 1 ⁰C/min temperature ramp was run from 35 ⁰C to 95 ⁰C and the 
ellipiticity of absorbed light was monitored at a wavelength of 218 nm (sensitive to β-
sheets). The data were then normalized and the apparent melting temperatures inferred 
from the loss of 50% of the maximum signal.  
 127 







N U  ,     (Eqn. 6.4) 
where kunfold and kfold are the rates of unfolding and folding, respectively. An equilibrium 
constant for this reaction may be written as K = kunfold/kfold. We can write the 
concentration of native [N] and unfolded [U] protein in terms of the total protein 
concentration Co and the folded fraction F as [N] = CoF  and [U] = Co(1-F) and insert 
these relationships into the equilibrium constant: 









     .     (Eqn. 6.5) 
The Gibb’s free energy for the melting experiments may be determined using 
 
0 0lnG RT K H T S        .    (Eqn. 6.6) 
 If the heat capacities of the folded and unfolded antibodies are the same, then ∆H⁰ 
and ∆S⁰ are constant over the temperature range studied.47 Tm is taken as the temperature 
at which half of the protein is folded (F = 0.5): 
0 01 0.5( ) ln
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Combining equations 5, 6, and 8 we obtain the van’t Hoff equation, which is used 
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     (Eqn. 6.9)  
6.4 Results and Discussion 
6.4.1 Protein Concentration-Dependent Diffusion 
The interaction parameter for the hIgG1 was determined in a variety of saccharide 
solutions (Figure 1). The sign and magnitude of kD indicate whether the protein 
interactions are repulsive (positive kD) or attractive (negative kD) and how [relatively] 
strong those interactions are.
40
 All of the sugars increased kD compared to the control, 
suggesting that they all stabilized the protein to varying degrees. The kD values for the 
mono-saccharides (glucose, mannitol, sorbitol, and xylitol) were all similar despite 
differences in their molecular weight, oxidation state, and number of hydroxyl groups. 
The di-saccharides (maltose, sucrose, and trehalose) also yielded kD values comparable to 
each other (and greater than those obtained from the mono-saccharide solutions). A 
summary is presented in Table 6.1below.  
 
Table 6.1: Summary of results. Molecular weight MW, interaction parameters kD ± fitting 



























Buffer - -3279 ± 166 96.6 ± 11 5.6 72.3 - 77.6 ± 3.3 
Glucose 180.2 -2571 ± 146 42.2 ± 4 5.5 76.8 4.5 85.7 ± 3.9 
Maltose 342.3 -1947 ±315 - 5.6 79.6 7.3 96.4 ± 4.8 
Mannitol 182.2 -2564 ± 199 55.9 ± 9 5.2 77.2 4.9 87.9 ± 3.4 
Sorbitol 182.2 -2532 ± 94 42.1 ± 3 5.5 77.2 4.9 95.2 ± 1.7 
Sucrose 342.3 -1684 ± 117 17.4 ± 3 5.5 80.8 8.5 86.4 ± 3.7 
Trehalose 378.3 -2023 ± 194 27.2 ± 13 5.4 78.4 6.1 133 ± 6.5 
Xylitol 152.2 -2460 ± 32 - 5.4 75.7 3.4 111.5 ± 5.3 
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 Our calculation of kD assumes that concentration-dependent changes in diffusivity 
and apparent protein size are a result of protein – protein interactions and not changes in 
the actual size of the protein. While the actual size of some proteins may change with 
concentration through reversible self-association, unfolding upon dilution, or 
aggregation, we do not believe this is the case here.
37, 38
 Self-association, should be 
reflected in the polydispersity. For all of our experiments we consistently observed a 
polydispersity index of 0.1 (the lowest possible reading for the instrument), so we 
conclude that our kD measurements detect the monomeric antibody and are truly 
measures of protein – protein interactions.   
 
Figure 6.1: Normalized mutual diffusivity versus protein concentration. kD from the 
slope of the curves above (Eqn. 6.1). 
 
6.4.2 Thermally-Induced Dimerization 
Aggregation was induced thermally at 45 ⁰C to evaluate how much stabilization the 
sugars afforded our hIgG1. Little or no aggregation was detected at 35 ⁰C and 
aggregation proceeded too rapidly to accurately capture the initial stages at 55 ⁰C (data 
 130 
not shown). Figure 6.2 shows the evolution of the protein radius as seen by DLS in a 
representative aggregation experiment from which k11 can be calculated. The k11 values 
for all the sugars tested are presented in Table 6.1.  
At 500 mM all of the sugars tested slowed the rate of aggregation compared to the 
buffered control. Aggregation in di-saccharide solutions was notably slower than 
aggregation in the presences of the mono-saccharides. Di-saccharides slowed aggregation 
compared to the control by a factor of about four, whereas mono-saccharides slowed 
aggregation by a factor of approximately two (Table 1). The greater stabilization in di- 
versus mono-saccharides may be a result of greater viscosity or to greater exclusion of 
the sugar from the protein surface.
16, 17
 Regardless of the mechanism, these stress tests 
clearly indicate that sugars like sucrose and trehalose significantly enhance our 
aglycosylated antibody’s stability against aggregation.  
 
Figure 6.2: hIgG1 aggregation in buffer at 45 ⁰C over 65 hours. The y-intercept is the 
initial radius (Ro) and slope (dR/dt) is rate of aggregation. See Chapter 5 for a detailed 





6.4.3 Apparent Melting Temperature and Melting Intermediate 
The antibody’s apparent melting temperature Tm,app was determined in various 
sugar solutions via CD. These Tm values are “apparent” because the unfolding is partially 
kinetically controlled, and an absolute Tm measurement would require an infinitely 
(impractically) slow ramp rate. The reported Tm,app are nonetheless a consistent, 
reproducible approximation of Tm, and useful for comparing different formulations.  
   
 
Figure 6.3: CD melts of aglycosylated hIgG1 in (A) buffer and (B) trehalose read at 218 
nm. Full spectra scans every 5 ⁰C are shown for (C) buffer and (D) trehalose. The blue to 
red color gradient corresponds to traces from 30 to 95 ⁰C, respectively. A melting 




Figure 6.3A shows the melt of the hIgG1 in the buffer. While it is possible to distinguish 
two melting transitions at ~71 ⁰C and ~79 ⁰C corresponding to the denaturation of the 
Fab and then Fc domains
48
 in Figure 6.3A, such a distinction was not possible for CD 
melts with sugars, as in Figure 6.3B; consequently, a single Tm,app is reported for all 
melts. The Tm,app reported is the temperature at which the CD signal is half its maximum 
(i.e. 50% of the signal from the top of the hump). Melting temperatures determined at 
50% decay of the initial baseline correlate well to Tm,app determined from the top of the 
hump (R
2
 = 0.996, Fig. 6.4). A collection of all the Tm,apps is presented in Table 6.1 along 
with ∆Tm,app ( , , ,
Sugar Buffer
m app m app m appT T T   ).  
All the sugars are seen to improve thermal stability, and again the effect is more 
pronounced for the di-saccharides than for the mono-saccharides. The added stabilization 
of the sugars ranged from increasing Tm,app by 3.4 ⁰C in xylitol to 8.5 ⁰C in sucrose. Other 
researchers have observed that sugars also increase the Tm of model proteins.
15, 18, 23, 40
 
Kaushik and Bhat suggest the mechanism of this phenomenon is due to sugars (and other 
polyols) influencing water-mediated effects, such as increasing surface tension and 
preferentially hydrating proteins,
18
 much like kosmotropic anions do.
49
 These effects 
encourage the native state by making the expansion of the protein – solvent interfacial 
area associated with unfolding energetically unfavorable. Crowding forces are likely also 





Figure 6.4: Correlation between Tm determined by baseline and hump normalization.  
 
During our melts in sugar solutions, the CD signal notably increased before the 
protein completely melted, as can be clearly seen in the presence of trehalose (Fig. 6.3B). 
This hump was reproducibly apparent in all experiments with sugars. The ratio of the top 
of the hump to the initial, native baseline was unchanged when protein concentration was 
changed and the hump was found to be reversible (Fig. 6.5). DLS melts (performed as 
previously published
51
) were unable to capture the hump (or differentiate between 
solvents), as DLS is insensitive to details of the folding structure (Appendix C). We 
therefore hypothesize that prior to melting this antibody enters a sugar-stabilized 
intermediate that gives a stronger CD signal than the native antibody.  
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Figure 6.5: Forward then reverse temperature ramp in 500 mM Trehalose. Both ramps 
were performed at a rate of 1 ⁰C/min. The temperature was held at 73 ⁰C (the maximum 
temperature of this ramp) for 15 minutes to evaluate the kinetic stability of the melting 
intermediate. 
 
We therefore hypothesize that prior to melting this antibody reversibly forms a 
sugar-stabilized intermediate that yields a stronger CD signal than the native antibody. In 
principle, the onset of protein melting can also be detected with DLS,
51
 but since DLS is 
insensitive to details of the folding structure, we did not pursue it here. Instead, we found 
our hypothesis corroborated by looking at the full wavelength spectra over the course of a 
melt (Figures 6.3C & D). The native protein and fully denatured protein have distinct CD 
spectra. If the melt was two-state (N↔U), then - by the principle of superposition - the 
CD spectra for all temperatures would be some combination of those two spectra. In 
particular, for any wavelength at which the spectra of the native and the unfolded state 
coincide, the CD signal should remain constant as one population increases and the other 
decreases. Thus a two-state system with crossing CD spectra for the two states 
necessarily contains an isosbestic point, and by extension, the absence of an isosbestic 
point indicates that the system does not simply undergo a transition between two states 
but evolves through at least one intermediate state.
52, 53
 It should be noted that the 
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presence of an isosbestic point does not preclude the possibility of a three-state system; 
but its absence eliminates the possibility of a two-state system.  
CD spectra from 30 ⁰C to 95 ⁰C in buffer and trehalose are presented in Figures 
6.3C and D, respectively. Both figures show a peak at 234 nm and a well at 218 nm in the 
native spectra (blue curves). The spectra for the denatured protein in both figures are 
significantly flatter and provide weaker signals (bright red curves). As the native spectra 
decay towards the denatured spectra, we can clearly see that the traces at 65 and 70 ⁰C in 
Figure 6.3C and the traces between 70 and 80 ⁰C in Figure 3D are not a mixture of the 
native and denatured spectra but distinctly different curves. This distinction is observed 
over a wider temperature range and produces a stronger signal in trehalose solution (Fig. 
6.3D) than in buffer only. Neither Figure 6.3C nor D contains an isosbestic point, so we 
may deduce that the hump observed during our melts is an ephemeral, sugar-stabilized 
intermediate.  
The enthalpies of melting (∆Hm) were calculated from the top of the intermediate 
hump to the fully denatured baseline (Table 6.1). The two state model assumed earlier for 
enthalpy calculation thus corresponds to unfolding of the intermediate I ↔ D, rather than 
N ↔ D. The inferred melting enthalpies are similar to those previously reported in the 
literature for other antibodies.
48, 54
 All ∆Hm values were larger than for the buffered 
control. The increased ∆Hm imply that more heat is required to completely unfold the 
antibody in sugar solutions. These results agree with the notion that unfolding in sugar 






6.4.4 Correlating Stability Metrics 
To assess the usefulness of the interaction parameter as a predictor of aggregation 
propensity and thermostability, we studied the correlation of kD with k11 and with Tm,app 
(Figures 6.4A and B, respectively). Both plots revealed strong, roughly linear correlations 
with a squared correlation coefficient R
2
 ≥ 0.91, suggesting that kD is indeed a good 
predictor of antibody stability in saccharide solutions.  
 
Figure 6.6: Correlations of kD with (A) k11 and (B) Tm,app. Error for all data sets is 
presented in Table 6.1. 
 
For media of different salt composition, we previously reported a strong 
correlation between kD and protein stability, with both properties showing trends familiar 
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from the Hofmeister series.
29, 31
 Unlike salts, which produce electrostatic and ion-specific 
effects and can either enhance or reduce protein stability,
55
 all sugars tend to have the 
same qualitative effect proteins. Despite this similarity in saccharide – protein 
interactions, kD was seen to resolve subtle quantitative differences in the effect of 
different sugars and correlate well with aggregation tests and CD melts. In the absence of 
a ranking system for sugars analogous to the Hofmeister series for salts, the fast stability 
assessment for protein-sugar solutions afforded by the interaction parameter kD should 
prove especially useful for protein formulations.  
 
6.5 Conclusion 
We have shown that both the thermostability and the colloidal stability of an 
aglycosyalted human IgG1 in solution can be improved by sugar excipients. The relative 
magnitude of these stabilizing effects for different sugars can be gauged by analyzing the 
diffusive virial coefficient kD, an interaction parameter accessible fast, without sample 
loss, and in a high-throughput manner by diffusivity studies using dynamic light 
scattering. A detailed circular dichroism analysis further suggests that thermally induced 
unfolding proceeds via a reversibly formed intermediate state that is stabilized by sugars.  
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THE CELLULOSE-BINDING DOMAIN OF 
CELLOBIOHYDROLASE CEL7A FROM TRICHODERMA RESSEI 
IS ALSO A THERMOSTABILIZING DOMAIN 
 
This chapter is adapted from our research published in the Journal of Biotechnology 
2011, 155 (4): 370-376. Mélanie Hall contributed as much as Jonathan Rubin did to this 
work. Sven Behrens and Andreas Bommarius also contributed to this work. 
 
7.1 Abstract 
The thermostability of cellobiohydrolase I Cel7A from Trichoderma reesei was 
investigated using dynamic light scattering. While the whole enzyme displayed a melting 
temperature of 59 °C, the catalytic domain obtained via papain-catalyzed proteolysis was 
shown to denature at 51 °C, and the cellulose-binding domain (with linker attached) 
melted between 65 – 66 °C. This variation in individual melting temperatures is proposed 
to account for the full retention of binding capacity of Cel7A at 50 °C, along with a loss 
of catalytic activity observed for the catalytic domain alone. Thus, the cellulose-binding 
domain of Cel7A acts as a thermostabilizing domain for the enzyme. The effect of 
reducing agents on the protein melting behavior was also investigated. 
 
7.2 Introduction 
Glycosyl hydrolases catalyze the hydrolysis of a wide variety of polysaccharides, soluble 
or insoluble, and have been categorized into more than 100 families according to 
 144 
sequence-based classification (120 as of December 2010, see Carbohydrate Active 
Enzymes database; URL http://www.cazy.org/).
1
 Cellobiohydrolases (E.C. 3.2.1.91) are 
exoglucanases which cleave off cellobiose, a glucose dimer, from the chain ends of 
cellulose. Type I cellobiohydrolases are specific for reducing ends whereas type II are for 
non-reducing ends. These enzymes have been extensively studied at the structural and 
mechanistic level. Cel7A, a cellobiohydrolase I, is the major cellulolytic enzyme 
produced by Trichoderma reesei (anamorph of Hypocrea jecorina) and is currently one 
of the most investigated cellulases for biofuel applications. Major improvements are 
required in the enzymatic hydrolysis of cellulosic biomass before cellulosic ethanol can 
compete economically with corn-derived ethanol or petrol.
2
  
Cel7A consists of three domains, (i) a 434 amino acid (aa) catalytic domain (CD) 
where glycosyl hydrolysis occurs,
3
 (ii) a 36 aa cellulose-binding domain (CBD) that 
anchors the enzyme onto the cellulose surface and allows processive motion along 
individual cellulose chains,
4
 and (iii) a 24 aa heavily O-glycosylated linker that connects 
these two domains. The linker likely transfers the energy required for processive motion 
from the CD (generated through the catalytic event) to the CBD and provides necessary 
spatial separation between the two domains.
5-8
  
The hydrolysis of cellulose with cellulases is usually carried out at moderate 
temperatures (50 °C is frequently encountered), due to the relatively low thermostability 
of cellulases from mesophilic organisms. Current research trends are directed towards 
using cellulases from extremophiles and improving their thermostability, a property 
favorable from an industrial process perspective. Increasing the process temperature 
lowers the viscosity of the system, leads to higher specific activities,
9
 and is significant 
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for overall improvement of the system (such as optimization of mass transfer rates and 
reduction of possible microbial contamination
10
). The ability to do so without 
compromising the stability of the catalyst represents a major challenge.  
A variety of techniques including directed evolution, rational design, and use of 
structure-guided consensus
11-13
 have been employed to enhance the thermostability of 
enzymes; some successful cases have been reported for cellulases specifically. 
Voutilainen et al. (2007) applied random mutagenesis to Melanocarpus albomyces 
cellobiohydrolase Cel7B and obtained single variants with improved unfolding 
temperature (Tm) that also showed more effective hydrolytic activity at higher 
temperature than the wild-type.
14
 They also successfully employed structure-guided 
protein engineering to improve both Tm and activity at elevated temperature of 
cellobiohydrolase Cel7A from Talaromyces emersonii.
15
 The use of SCHEMA, a 
computational approach to identifying blocks of sequence that minimize structural 
disruption when they are recombined in chimeric proteins, proved successful in creating a 
family of thermostable cellobiohydrolases II chimeras that displayed greatly enhanced 
half-lives of thermal inactivation.
16
 The same approach was recently applied to 
cellobiohydrolases I.
17
 In all these examples, the mutated residues were located within the 
catalytic domain and not the cellulose-binding domain. Yet, this binding domain may 
also play an important role for the overall thermostability of cellulases, as suggested 
indirectly by recent examples of increased activity at 70 °C of thermophilic single 
module GH-7 family cellobiohydrolase
18
 and endoglucanase catalytic domains
19
 upon 
fusion with mesophilic cellulose-binding domains. So far, the thermostability and 
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thermostabilizing property of the CBD of cellulases have not been investigated 
independently.  
While investigating the potential use of the cellulose-binding domain of Cel7A 
from T. reesei in a pretreatment step of cellulose for more efficient enzymatic hydrolysis, 
we discovered that the binding capacity of full-length cellulases was retained after 
extended incubation time at 50 °C (cellulose-binding domain specific property) while 
their catalytic activity was dramatically reduced (catalytic domain-specific property).
20
 
Intrigued by these results, we initiated a study to compare the respective responses of 
CBD, CD and Cel7A to heat treatment with or without reducing agents present. This 
study is the first to monitor temperature-induced transitions in Cel7A and in its 
constituent domains (CD and CBD) separately. Light scattering measurements with a 
combined evaluation of intensity fluctuations and time-averaged scattering intensities 
were used to detect the onset of unfolding and aggregation for each of the domains and 
Cel7A as a whole. 
 
7.3 Materials and methods 
 
7.3.1 Materials 
Avicel PH-101, cellulases from T. reesei (159 FPU mL
−1
), and β-glucosidase (from 
almonds, 2.32 U mg
−1
) were obtained from Sigma (St. Louis, MO, USA). The [micro] 
BCA protein assay kit and the Coomassie (Bradford) protein assay kit were obtained 
from Thermo Fischer Scientific (Rockford, IL, USA). Papain was obtained from Fluka as 
lyophilized powder from Carica papaya (9.84 U mg
−1
). Centrifugal devices with 
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polyethersulfone membranes (‘Jumbosep’ and ‘Macrosep’) were from Pall Life Sciences 
(Ann Arbor, MI, USA). All experiments and assays were run at least in duplicate. 
 
7.3.2 Cel7A Purification  
Cel7A was purified from T. reesei cellulase cocktail by means of anion-exchange 
chromatography as previously published.
21
 Purity was confirmed by SDS-PAGE.
20
 After 
purification, Cel7A’s buffer was exchanged to sodium acetate buffer (50 mM, pH 5) 
through multiple dilution/concentration iterations using a polyethersulfone membrane 
(molecular weight cut-off of 10 kDa) in a Macrosep device. 
 
7.3.3 Cellulase Proteolysis and CBD Isolation 
Cellulase cleavage using papain was adapted from published procedures
22,23
 using 
purified Cel7A solution prepared as described above and stored in sodium acetate buffer 
(50 mM, pH 5). Papain was activated in ammonium acetate buffer (50 mM, pH 6) at 30 
°C and 170 rpm for 30 min and added to Cel7A solution (1:5, w/w; 1:5, v/v). The 
digestion was performed at 30 °C for 2 h (completion checked via SDS-PAGE). The 
mixture was then filtered through 30 kDa membrane. The filtrate (containing the CBD) 
was diluted and passed through a 30 kDa membrane again to ensure no CD 
contamination. The diluted CBD solution was subsequently concentrated using a 3 kDa 
membrane. Both the CD and CBD solutions were analyzed for protein content using the 




7.3.4 MALDI-TOF Mass Spectrometry 
Purified CBD was obtained as described above, except that the buffer was ammonium 
acetate 50 mM pH 6.0 which was used in place of sodium acetate to drastically improve 
the signal-to-noise ratio in the mass spectrometer (MS). MALDI-TOF MS was performed 
on a PerSeptive Biosystems Voyager-DE STR (Framingham, USA). The spectra were 
acquired in linear mode, and the matrix used was sinapinic acid. A 10 mg mL
−1
 solution 
of the matrix was made in 50:50 (v:v) water:acetonitrile containing 0.1% formic acid by 
volume. Equal volumes of the matrix solution and the CBD solution were mixed, and the 
resulting solution was spotted onto the MALDI plate. A total of 500 laser shots were 
combined to produce the final spectrum. 
 
7.3.5 Cellulose Enzymatic Hydrolysis 
Cellulases and catalytic domains were incubated at 50 °C for 15 h and then added (300 
μg mL
−1
 and 125 μg mL
−1
, respectively) to a cellulose mixture (20 mg mL
−1
 in sodium 
acetate buffer, 50 mM, pH 5) that had been incubated at 50 °C for 1 h at 900 rpm. The 
hydrolysis was run at 50 °C and 900 rpm and the conversion was monitored after 6 h and 
22 h by performing DNS assay on the supernatant. 
 
7.3.6 Enzyme Adsorption Experiments 
Avicel samples (20 mg mL
−1
) in sodium acetate buffer (50 mM, pH 5) were incubated at 
50 °C for 1 h at 900 rpm, and then cooled down to 4 °C. Cellulases (which had been 
incubated in sodium acetate buffer at 50 °C for 15 h or stored at 4 °C since purchase) 
were added in various amounts and the mixture was further agitated for 30 min at 4 °C. 
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After centrifugation, the supernatant was collected and protein content analysis was 
performed using the BCA protein assay kit. 
 
7.3.7 Dynamic Light Scattering and Tm Determination 
Purified samples were passed through a 0.02 μm aluminum oxide Whatman Anotop filter 
prior to light scattering measurements. DLS measurements were performed at a scattering 
angle of 90° in a Malvern Zetasizer Nano-ZS90 (Worcestershire, United Kingdom) and 
for the weakly scattering CBD probes under 150° angle, using a precision goniometer 
setup (ALV/DLS/SLS-5022F, Langen, Germany). In each case the hydrodynamic radius 
was obtained from a second order cumulant fit to the intensity autocorrelation function. 
For Cel7A and the catalytic domain, Tm was determined on the Malvern Zetasizer 
using a programmed temperature ramp from 30 °C to 70 °C with 1 °C min
-1
 increments. 
The sample was equilibrated for 1 min at each temperature set-point before taking a 
single 30 s measurement. The melting temperature was identified as the lowest 
temperature inducing a significant increase in hydrodynamic raidus Rh compared to the 
native state.  
For the much smaller CBD, DLS correlograms and intensity recordings were 
accumulated for 5 min at 150° angle for improved sensitivity using the precision 
goniometer setup. When no indication of protein melting was observed, the measurement 
was repeated after exposure of the sample cuvette to a PolyScience Digital Temperature 
Controller water bath for 5 min at an increasingly elevated temperature. The lowest bath 
temperature inducing a response in the scattering intensity and DLS size is reported as 
Tm. Application of this method to the full-size Cel7A confirmed the melting point value 
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determined independently with the Zetasizer as described above to within 1 °C, thus 
validating the approach for the CBD. 
Melting temperature experiments were also conducted in the presence of reducing 
agents. Concentrated dithiothreitol (DTT) and β-mercaptoethanol solutions were prepared 
in 50 mM sodium acetate buffer pH 5.0. The concentrated DTT or β -mercaptoethanol 
solution was then diluted with Cel7A, CD or CBD. The peptide/reducing agent sample 
was gently stirred, then equilibrated at room temperature (22 ± 1 °C) for 5 min before 
measurements were taken. The melting temperatures for each reducing agent/peptide 
combination were determined as described above. 
 
7.4 Results and discussion 
 
7.4.1 Activity, Binding, and Melting Points 
The purity, homogeneity, and kinetic thermostability of Cel7A and the CD were 
confirmed via DLS (Figs. 7.1 and 7.2). The samples were held at elevated temperatures 
for 2 hours then their size distributions were recorded. Figures 7.1 and 7.2 clearly show 
that the samples are homogeneous and thermo-tolerant below their Tms. Sizes of the 
native state are shown in Table 7.1 (Note: Figures 7.1 and 7.2 report the diameter and 
Table 7.1 reports the radius). 
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Figure 7.1: DLS size distribution profile for purified Cel7A after 2 hour incubation at 
30°C.  
 
Figure 7.2.:DLS size distribution profile for purified CDCel7A after 2 hour incubation at 
45 °C.  
 
The melting temperatures Tm of Cel7A and CD  were determined by analyzing the 
apparent protein size during a linear temperature ramp (Figs. 7.3 and 7.4); results for Tm 
are summarized in Table 7.1. The melting point of a protein is defined as the temperature 
at which the protein denatures. Protein unfolding is accompanied by an increase in size 
and can lead to protein aggregation and thus to further growth. Dynamic light scattering 
(DLS) provides a fast and convenient way to monitor the size of proteins, whose 
diffusivity and hydrodynamic radius Rh are inferred from intensity fluctuations of light 
scattered by the sample under coherent illumination.
24,25
 This method has been already 
used to assess the stability of various proteins. It was used for instance in the 
determination of BSA surfactant-induced unfolding and gave results in good agreement 
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with small-angle neutron scattering (SANS).
26
 DLS has also proved useful in thermal 





 α-amylase from Bacillus licheniformis,
29
 and the 
extracellular hemoglobin of Glossoscolex paulistus HbGp
30
 and agreed with circular 
dichroism and fluorescence spectroscopy.
31
 
Fig. 7.3 (full markers) illustrates the size change of Cel7A upon thermal 
denaturation. The observed sharp increase in hydrodynamic radius provides a clear-cut 
melting point Tm of 59 °C (±1 °C), which agrees well with a previous estimate of 62 °C 
(±2 °C) obtained from circular dichroism and tryptophan fluorescence.
32
 In Chapter 6, we 
also found that DLS determined melting temperatures were lower than CD Tms for our 
IgG1. The reason for the discrepancy in Tms between the two techniques is likely due to 
differences in Tm-determination convention. 
 
Table 7.1: Hydrodynamic radii Rh (obtained at room temperature) and melting 
temperature Tm of Cel7A and its fragments as determined by DLS. The buffer was 50 
mM acetate at pH 5.0. Due to the lower concentration of CBD, 1 mM of each reducing 
agent was used in those melts. 
Protein Rh (nm) 
Tm (⁰C) 
Buffer DTT (3mM) β-mercaptoethanol (3mM) 
Cel7A 4.2 ± 0.5 59 ± 1 59 ± 1 59 ± 1 
CDCel7A 3.4 ± 0.5 51 ± 1 61 ± 1 60 ± 1 
CBDCel7A (with 
linker) 
< 1 65.5 ± 0.5 61.5 ± 0.5 63.5 ± 0.5 
 
 
Figure 7.3 also reports the (time averaged, open markers) scattering intensity. For 
scattering objects much smaller than the wavelength of light used (633 nm in the present 
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experiments), the scattering intensity is highest in a condensed, compact conformation;
33
 
therefore, both protein folding and protein aggregation promote a high scattering 
intensity. The slight drop in intensity observed along with the initial increase in particle 
size between 59 and 64 °C (Fig. 7.3B) is thus indicative of protein unfolding, whereas the 
intensity increase above 65 °C clearly points at aggregation. At the conclusion of the 
experiment, the initially clear enzyme solution was very turbid and precipitate had 
formed. A reverse, linear temperature ramp back to room temperature proved that 





Fig. 7.3. DLS temperature ramp experiments with Cel7A. (●) Hydrodynamic radius (nm) 
and (o) scattering intensity (kcps) on (A) full scale, and (B) zoomed portion of (A) 
between 50 and 64 °C to show unfolding behavior. 
 
The catalytic domain exhibits a different melting behavior than the full enzyme 
(Fig. 7.4). In this case, the increase in Rh already sets in at Tm = 51 °C, and coincides 
directly with an increase in scattering. This result indicates that aggregates are 
instantaneously formed upon denaturation of the CD, likely due to hydrophobic patches 
from different unfolded proteins associating with one another (large aggregates were 
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visible to the naked eye after completion of the temperature ramp). This difference in 
thermal stability between the CD and the full enzyme could not be attributed to the CD 
preparation procedure (2 h at 30 °C during papain cleavage). A control experiment with 
Cel7A was performed where it was incubation for 2 h at 30 °C prior to DLS temperature 
ramp. No difference in Tm was observed.  
 
 
Fig. 7.4. DLS temperature ramp experiments with CDCel7A. (●) Hydrodynamic radius 
(nm) and (o) scattering intensity (kcps). 
 
The purity of the CBD sample was of the utmost importance before determining 
its melting point because even trace amounts of the much larger CD (not visible on SDS-
PAGE gel at very low concentration) would significantly skew the size measurements 
and affect melting behavior. MALDI-TOF mass spectroscopy confirmed the purity of the 
CBD and also showed the absence of larger molecules (Fig. 7.5A).
20
 The different 
degrees of glycosylation on the linker account for the observed handful of peptides 
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separated by an average of 162 Da (this mass corresponds to the mass of dehydrohexoses 
of the O-glycosylated residues).  
Characterizing the thermostability of the CBD with DLS proved challenging 
because of the small domain size (<70 residues, with linker, total size ~8.4-9.4 kDa as 
measured by MALDI-TOF, Fig. 7.5A) and poor optical contrast, resulting in an 
extremely weak light scattering signal. Although the exact size of the individual binding 
domain could not be measured precisely, we can safely assert that the hydrodynamic 
radius lies well below 1 nm. The CBD melting temperature could be determined more 
reliably, however, since aggregates formed upon melting are more easily detectable. The 
technique employed here is akin to the established method for detection of surfactant 
aggregates by DLS, which allows the estimation of the critical micelle concentration of 
surfactant molecules that cannot be detected in the non-aggregated state.
34
 As indicated in 
Fig. 7.5B, the CBD size remained below the DLS detection limit (<1 nm) after exposure 
to temperatures up to 65 °C. After heating to 66 °C, however, an increase in the scattering 
intensity was observed and a quantitative interpretation of DLS data was possible. It 
suggests that the signal was dominated by aggregates with a hydrodynamic radius of 
approximately 1 μm. When heated above 66 °C, the solution became visibly turbid. The 
CBD thus displays a melting temperature of 65.5 °C (±0.5 °C), higher than the value for 
the full enzyme by at least 6 °C and much higher than the value for the catalytic domain 
(by at least 14 °C).  
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Fig. 7.5. CBDCel7A purity and melting experiments. (A) MALDI-TOF on CBD in 50 mM 
ammonium acetate pH 6.0 with inset showing full scale m/z up to 40 kDa; (B) scattering 
intensity (kcps) as a function of temperature. 
 
Like the CD and unlike the full Cel7A, the CBD was characterized by a single 
threshold temperature for unfolding and aggregation. The hypothesis that this different 
behavior of Cel7A is related to a non-cooperative unfolding is tempting. However, if the 
CBD unfolding within Cel7A indeed occurs at a temperature above the melting point of 
the whole protein, then its effect on the light scattering signal is masked by the CD-
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induced protein aggregation; a sequential unfolding of the different components therefore 
cannot be established unequivocally. From the present results though, it is obvious that 
the CBD (with linker attached) confers thermostability to the full-length enzyme and it 
can thus be described as a thermostabilizing domain (TSD). Such domains have been 
reported to exist with xylanases, though the whole machinery there is more complex 
since these enzymes are often composed of catalytic domains linked to one or more 
noncatalytic domains (including CBDs, TSDs and S-layer-like domains). These xylanase 
TSDs appear to have other prevailing function than thermostabilization, such as xylan 
binding (and references within).
35
 Such a TSD for instance was added to a xylanase CD 
and the resulting protein had enhanced thermostability as well as enhanced binding 
capacity towards xylan and higher activity on insoluble xylan, proving its dual function.
35
 
Our data also support the dichotomous behavior observed after incubation of 
cellulases and their CDs at 50 °C (Table 7.2). Over 100% of binding activity was retained 
after cellulases were incubated at 50 °C for 15 h (implying that the CBDs were still 
functional and thus folded) but their catalytic activity (and that of the CDs) was 
dramatically reduced. While the enzymes could retain 57% of their original activity after 
incubation at 50 °C for 15 h, the CDs retained only 42%, demonstrating that they are less 
thermo-tolerant than the full-length enzymes. This phenomenon is understandable with 
the CDs (given an incubation temperature only 1 °C lower than the Tm, suggesting that 
the denaturation process has begun and led to a loss of catalytic activity). The reduced 
activity is more difficult to explain for the full-length enzyme (Tm of 59 °C), except if 
there is some partial unfolding of the protein at the CD level (but CBD stays intact). Such 
a partial denaturation (see discussion above) could not be clearly demonstrated by DLS 
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techniques, however, as no increase in the overall hydrodynamic radius of Cel7A at 50 
°C was detected (Fig. 7.3). Thus the loss of catalytic activity of cellulases observed at 50 
°C is a kinetic rather than thermodynamic stability issue
36
  since the proteins are expected 
to remain folded at this temperature. It is therefore likely that a gradual denaturation 
process has started after prolonged incubation at 50 °C (a temperature below their Tm) 
leading to reduced catalytic activity but no detectable structural changes, i.e. some 




Table 7.2: Residual binding capacity and catalytic activity after incubation at 50 °C for 
15 h (reference: 100% from cellulases employed after storage at 4 °C). The two binding 
capacities reported for the native cellulases correspond to different enzyme/cellulose 
loadings: 
a
 90 μg/mg and 
b
 150 μg/mg. 
 Native Cellulases CDs 






Catalytic activity (6 h reaction time) 57% 42% 
 
It is also worth noting that the melting point in this particular case was not 
correlated with the protein molecular weight (MW) (CBD Tm > Cel7A Tm > CD Tm and 
CBD MW < CD MW < Cel7A MW, Table 7.1). 
 
7.4.2 Influence of Reducing Agents 
The CBD structure resembles a wedge-like fold, where a flat face provides key 
(aromatic) residues strongly interacting with crystalline cellulose and the whole domain 
is stabilized by two disulfide bridges.
4,38
 Reducing the disulfide bonds likely has an effect 
on the whole folding of the CBD, and therefore its binding capacity, as a disruption of the 
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hydrophobic residues arrangement on the flat face would most probably result in a 
complete loss of interaction with the cellulose surface (it has been reported that reduced 
Cel7A had lost binding ability on cellulose, i.e. the disulfide-bonded conformation is 
essential for binding
39
). We initiated experiments to investigate further the role of these 
bonds on the CBD properties, suspecting that they strongly influenced the thermostability 
and the denaturation process. 
Variations in the Tm of Cel7A were monitored via DLS using various reducing 
agents (DTT and β-mercaptoethanol). The effect of reducing agents on Cel7A melting 
point was practically not observable (Table 7.1), even at 20 mM reducing agent 
concentration (data not shown). The temperature of unfolding was not affected; however, 
the reducing agents did stabilize the unfolded protein and prevented aggregation. The 
final solution was clear and the scattering intensity did not increase, demonstrating a lack 
of aggregation. This behavior is similar what one would expect in strongly chaotropic or 
surfactant solutions (as discussed in Chapter 1). 
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Fig. 7.6. Effect of reducing agents on CDCel7A and CBDCel7A Tm. (A) Temperature 
dependence of hydrodynamic radius Rh (nm) for CDCel7A containing no reducing agent 
(●), 3 mM β-mercaptoethanol (■), or 3 mM DTT (♦) and of scattering intensity (kcps, 
open symbols). (B) Temperature dependence of scattering intensity (kcps) for 
CBDCel7A solutions containing no reducing agent (○), 1 mM β-mercaptoethanol (□), or 
1 mM DTT (◊). 
 
A surprising effect was obtained with CD where both DTT and β-
mercaptoethanol stabilized both folded and denatured forms of the protein. Indeed CD Tm 
increased by 9–10 °C while no jump in scattering intensity was observed at the Tm (Fig. 
7.6A), which indicates the absence of aggregates (the solution remained clear), 
traditionally formed upon CD unfolding. Unfolding, though delayed, did occur, as shown 
by a substantial increase in the hydrodynamic radius, but the unfolded proteins were 
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stabilized against aggregation by the reducing agents. Protein aggregation is often due to 
the formation of intermolecular disulfide bridges between cysteine residues that became 
accessible after unfolding of the protein
40
  and reducing agents such as DTT thus provide 
a reducing environment that prevents oxidation of cysteine residues and subsequent 
aggregation. 
With the CBD however, the opposite (and more expected) behavior was observed: 
both reducing agents were found to decrease CBD Tm by 3–4 °C (Table 7.1 and Fig. 
7.6B). Since the disulfide bridges were chemically reduced, less energy was required to 




Overall, dynamic light scattering proved to be a powerful non-invasive method to 
investigate temperature-induced conformational changes in a multi-domain protein and 
its constituent domains separately. The cellulose-binding domain of Cel7A from T. reesei 
was unambiguously shown to be also thermostabilizing the whole protein: alone, it 
displayed a melting point 14–15 °C higher than that of the catalytic domain and 6–7 °C 
higher than that of the whole protein. This conclusion is further supported by kinetic data 
showing that CD alone losses significantly more catalytic activity than the full enzyme at 
elevated temperatures. 
Reducing agents such as DTT decreased the thermostability of the binding 
domain, pointing at disruption of otherwise stabilizing disulfide bridges. Efforts to 
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improve the thermostability of cellulases possessing structurally similar binding domains 
should concentrate on preserving or amplifying this intrinsic property. 
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CONCLUSIONS, PERSPECTIVES, AND RECCOMENDATIONS 
 
Proteins are incredibly versatile molecules. They are antibodies, enzymes, prions, 
chaperones, and hormones. They are an essential component of life, and maintaining their 
stability is a compulsory aspect of survival. Organisms have developed complex stress 
response systems and crude cryptobiotic mechanisms to ensure the physical stability of 
their proteins in the event of environmental change.
1-3
 Like an organism, proteins actuate 
biotechnological processes as well. Proteins catalyze reactions and are the products. The 
biochemical engineer’s cardinal objective is to ensure continual protein stability and 
operational harmony. The engineer’s toolbox is ever expanding with new strategies and 
more fundamental understanding of biomolecular processes.
4-6
  
 Researchers can take two main routes to improving and establishing protein 
physical stability: (i) protein mutations and (ii) solution optimization. Protein 
mutagenesis is a powerful tool that can dramatically improve stability and catalytic 
efficiency;
6,7
 however, many rounds of mutation and a significant screening effort are 
required to develop an enhanced protein. These tasks are time-consuming, resources-
intensive, and not guaranteed to be productive. But with high risk comes high reward.
8-11
 
Whether the catalyst or biopharmaceutical is a wild-type or a mutant, determining the 
most favorable environmental conditions is a fundamental part of process or product 
development. Solution optimization is a less radical, yet highly-effective approach to 
protein stabilization. Factors, such as ionic composition, temperature, pH, and co-solutes 
affect all proteins: prions enzyme, antibodies or otherwise. These variables can protect 
the native protein from deactivation or, if not considered, can denature protein. Water-
mediated effects are the salient determinant of protein physical stability and 
understanding them is the crux of this dissertation. 
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 Ion – water affinity dictate ion-specific protein interactions.  For prion proteins in 
Chapters 2 and 3, chaotropes slowed aggregation because they kept Sup35NM 
monomeric and unfolded; while kosmotropes encouraged folding and, in turn, rapid 
aggregation. The differences in aggregation kinetics produced different prion variants 
that had varied morphologies and infectivity. Results from Chapter 3 combined with 
findings by Chen et al.
12
  bolstered our argument that salts induce different prion strains. 
While Chapter 2 provides a satisfying explanation of how and why prion strains form in 
different salts, the question remains as to whether strain formation is unique to salts or is 
it a kinetic phenomenon. If amyloid was formed quickly in sucrose, or close to the 
isoelectric point (this would probably form amorphous aggregates), or at high 
temperature would we then form strong [PSI
+
]? Is the converse true? That is, would 




 Part of this question has already been answered by Jonathan Weissman, who has 
shown that at low temperatures we form strong [PSI
+





 However, the literature is inconsistent when reporting the kinetics of 
temperature induced aggregation.
14,15
 Some report that amyloid formation at 4 ⁰C is 
slower than at 37 ⁰C, others report the opposite. Future work should conclusively 
elucidate the effect of temperature on Sup35NM aggregation kinetics.  
 The major question or hypothesis relating to this work that I’d like to forward for 
future work to examine is:  
 
Fast aggregation kinetics form imperfect amyloids, which in vivo are strong prions; 
conversely, slow forming amyloids are physically more stable and are weak prions. 
 
 In essence, this hypothesis postulates that aggregation kinetics dictate strains. This 
can be tested, first by looking at the well-characterized temperature system, then finding 
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another dichotomous environmental condition (e.g. high/low temperature, 
chaotrope/kosmotrope). I recommend looking at the effect of surface tension on amyloid 
formation. As mentioned in Chapters 1-3, on a molecular level Hofmeister effect are 
caused by differences in interfacial tension and water affinity. Whether or not the solute 
molecule is an ion may not matter. I posit that surfactants would act like chaotropes: 
reducing surface tension, slowing amyloid formation, inducing weak [PSI
+
]. Osmolytes, 
such as trehalose or sucrose, would act like kosmotropes: increasing surface tension, 
encouraging aggregation, and predominately producing strong [PSI
+
]. Other systems 
could certainly be tested, for example working at pH below Sup35NM’s pI (5.3). Would 
our findings be reversed at pH 4? Literature states that the Hofmeister series is inverted 
below a proteins pI,
16
 so potentially yes. Going forward, future work should be aimed at 
testing the hypothesis above and perhaps testing the same rational against other prion 
proteins to show if this hypothesis is universal or Sup35p specific. 
 Ion-specificity also plays a major role in pharmaceutical formulation. Chapters 4 
and 5 detail a rapid technique to predict the favorability of ion – protein interactions. In 
this case, chaotropes caused aggregation and kosmotropes were more stabilizing. 
Ostensibly, this behavior is the opposite of that seen in Chapter 2 and 3. The ions’ action 
in both cases is in fact, the same. The prions in Chapters 2 and 3 began unfolded and 
aggregate upon folding, whereas in Chapters 4 and 5 the protein began folded and upon 
unfolding they aggregated. Chapter 6 examined how well the protein – protein interaction 
parameter, developed in Chapter 4, gauged colloidal and thermal stability in saccharide 
solutions. Since Chapter 6 worked exclusively with sugars, which increase surface 
tension and all sugars stabilized, as kosmotropes did in Chapters 4 and 5. I believe that 
ionic interactions are not nearly as important as solute – water affinity in how a solute 
affects protein stability. This idea is very similar to the above discussion on prion kinetics 
and surface tension.  
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 Future work regarding the interaction parameter could look at applicability to 
other stabilizers, such as amino acids, or other solution conditions, such as pH. Although 
these experiments would be simple and quick to perform as our lab has competency in 
determining the interaction parameter in any solution, this research would be horizontal. 
 For more novel research on the interaction parameter, I propose a case study. The 
study would take a protein, such as the one in Chapter 6, and through solution alterations, 
maximize its kD. Sugars, salts, pH would be changed and the interaction would, in turn, 
be examine to see the positive [or negative] effects of the change. The product of the 
study should be a complete formulation, with a strongly positive kD. The formulation 
should then be corroborated by a long-term stability tests and characterizations to prove 
stability more conventionally. This study would show that kD can be used for more than 
just an initial screen and give a concrete application of how to formulate using our 
technique.  
 All in all, this dissertation has two major findings: (i) chaotropes and kosmotropes 
form different strains of [PSI
+
] and (ii) the interaction parameter can be used to rapidly 
predict protein stability in electrolyte or saccharide solutions. The common thread of 
protein stability and solvent conditions runs through-out this work. Hopefully the reader 
has a renewed appreciation and a deeper understanding of water-mediated effects on 
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MATLAB CODE FOR AMYLOID AGGREGATION KINETICS 
clear  
close all  
clc  
   
% This program takes kinetic data and fits it to a sigmoidal curve. The  
%outputs are the lag time (tlag), time till 50% maximum signal (thalf), and  
%slope @ thalf also known as the elongation rate constant k  
   
%Input time points for x  
x = […];  
   
 % Input fluorescent data for y. This data may or may not be normalized.  
% Depending on if the data is normalized, then initial guesses for  
% the fitting parameters below will need to be adjusted.  
   
y = […];  
   
options = statset('MaxIter',1000,'TolFun',10^-10,'TolX',10^-10);  
   
%These are the fitting parameters. A is the amplitude of the curve. If  
%normalized A will generally be unity, if not normalized A shoudl be set at  
%about the highest fluorescence value. K is the elongation rate constant. B  
%is the lag time guess. K and B do not depend on normalization. In the  
%event of very long lag times, increase the initial guess of B.  
A = 16000;  
K = 0.01;  
B = 200;  
   
   
% The kinetic data may not begin percisely at zero, so the model allows for  
% some offset. The following iterative loop attempts to find the most  
% appropriate offset with the range given  
   
range = [xxx:x:xxx];  
  for i= 1:length(range)  
    global offset  
    offset = range(i);  
 
%     The nlinfit is the non-linear curve fit to the above data. The data  
%     are passed to the curvelag funtion (another file)  
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    [k,R,J,COVB,MSE] = nlinfit(x,y,@curvelag, [A K B], options);     
 
    % R^2 error calculation used to determine accuracy of iteration  
 
    error(i) = sum(R.^2);  
    parameters(i,:)=k;  
 
    % calculation of thalf  
 
    thalf(i) = k(3)+2/k(2);  
end  
   
%Reassigning variables  
index = find(error==min(error));  
k = parameters(index,:);  
A = k(1);  
K = k(2);  
tlag = k(3);  
B = tlag;  
offset = range(index);  
thalf = thalf(index)  
   
%calculation of error  
yfit = k(1)./(1+exp(-k(2)*(x-(k(3)+2/k(2))))) + offset;  
   
SSE = sum((yfit - y).^2);  
SST = sum((y-mean(y)).^2);  
R2 = 1-SSE/SST;  
resid = yfit-y;  
   
%non-linear confidence interval calculation based on fitting error  
ci = nlparci([A K B], resid, 'jacobian', J);  
   
% Variable assignment of high and low confidence intervals (ci) for both k  
% and thalf (t12)  
kcilow = ci(2);  
kcihigh = ci(5);  
t12cilow = ci(3);  
t12cihigh = ci(6);  
tlagerr = tlag - t12cilow  
kerr = K - kcilow  
   
%output of k and tlag along with confidence intervals  
   
KCI = [kcilow, K, kcihigh]  
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tlagCI = [t12cilow, tlag, t12cihigh]  
   
   
 %The following is a separate .m file named “curvelag.m” 
      
 function [y] = curve(k,x,y)  
%This function takes the inputs given from the curvefitlag file and fits  
%them to the sigmoidal curve equation below  
   
global offset  
   
   
y = k(1)./(1+exp(-k(2)*(x-(k(3)+2/k(2))))) + offset;  
% residual = sum((ypred-y).^2);  
end  
 
   
   
   








TABULATED SPECIES BARRIER LAG TIMES 
 
Table B1: Data from Figures 3.3. Non-seeded lag times for S. cerevisiae, S. bayanus, and 
S. paradoxus. That background buffer for all experiments is PBS. Error reported is fitting 
error from the nonlinear MATLAB fit.  
Ion and concentration S. cerevisiae lag 
time (hr) 
S. bayanus lag time 
(hr) 
S. paradoxus lag 
time (hr) 
0.2 M sulfate 1.19 ± 0.23 1.86 ± 0.19 3.89 ± 0.24 
0.4 M sulfate 0.64 ± 0.37 1.41 ± 0.18 3.46 ± 0.53 
PBS 2.80 ± 0.13 2.52 ± 0.38 6.33 ± 0.15 
0.2 M chloride 4.29 ± 0.19 3.77 ± 0.38 7.65 ± 0.14 
0.4 M chloride 5.69 ± 0.06 4.92 ± 0.21 8.83 ± 0.07 
0.2 M perchlorate 7.32 ± 0.13 5.23 ± 0.41 12.5 ± 0.25 
















Table B2: Data from Figure 3.4. Seeded lag times for S. cerevisiae, S. bayanus, and S. 
paradoxus. That background buffer for all experiments is PBS. The seed donor is the 
species of the seed; the recipient is the species of the monomer. Error reported is fitting 
error from the nonlinear MATLAB fit.  
Monomer Recipient Salt Seed Formed In Species of Seed Donor Lag time (hr) 
S. cerevisiae Sulfate S. cerevisiae 0.30 ± 0.55 
S. bayanus 5.36 ±0.11 
S. paradoxus 0 ± 0.15 
Chloride S. cerevisiae 0 ± 0.18 
S. bayanus 4.51 ± 0.21 
S. paradoxus 2.68 ± 0.31 
Perchlorate S. cerevisiae 2.54 ± 0.12 
S. bayanus 4.88 ± 0.28 
S. paradoxus 4.37 ± 0.38 
- No Seed 2.80 ± 0.13 
S. bayanus Sulfate S. cerevisiae 5.67 ± 0.47 
S. bayanus 0 
S. paradoxus 4.81 ± 0.28 
Chloride S. cerevisiae 5.11 ± 0.12 
S. bayanus 0 
S. paradoxus 4.56 ± 0.36 
Perchlorate S. cerevisiae 5.00 ± 0.24 
S. bayanus 3.84 ± 0.24 
S. paradoxus 4.48 ± 0.28 
- No Seed 5.19 ± 0.38 
S. paradoxus Sulfate S. cerevisiae 2.97 ± 0.34 
S. bayanus 11.08 ± 0.20 
S. paradoxus 2.05 ± 0.39 
Chloride S. cerevisiae 7.01 ± 0.47 
S. bayanus 12.16 ± 0.49 
S. paradoxus 0 
Perchlorate S. cerevisiae 7.44 ± 1.54 
S. bayanus 12.3 ± 0.21 
S. paradoxus 0.84 ± 1.03 




Table B3: Data from Figure 3.5. S. bayanus and S. paradoxus monomer were seeded 
with S. cerevisiae seeds formed in different salt buffers. 0.4 M of additional salt was 
added to the PBS background buffer during heterologous seeding. Error reported is fitting 
error from the nonlinear MATLAB fit.  
Monomer Recipient Salt in Aggregation 
Solution 
Salt Seed Formed In Lag time (hr) 
S. bayanus Sulfate Sulfate 2.28 ± 0.44 
Chloride 1.65 ±0.53 
Perchlorate 1.63 ± 0.40 
Chloride Sulfate 5.38 ± 0.72 
Chloride 5.13 ± 0.30 
Perchlorate 6.64 ± 0.87 
Perchlorate Sulfate 6.95 ± 0.50 
Chloride >15 
Perchlorate >15 
None Sulfate 5.67 ± 0.47 
Chloride 5.11 ± 0.12 
Perchlorate 5.00 ± 0.24 
S. paradoxus Sulfate Sulfate 1.92 ± 0.32 
Chloride 2.94 ± 0.16 
Perchlorate 0 
Chloride Sulfate 9.17 ± 0.71 
Chloride 12.98 
Perchlorate >15 
Perchlorate Sulfate >15 
Chloride >15 
Perchlorate >15 
None Sulfate 2.97 ± 0.34 
Chloride 7.01 ± 0.47 





Pertaining to data from chapter 5: 
 
Figure C1: CD determined melting temperatures of the glycosylated (A) and 
aglycosylated (B) antibodies from Chapter 5. Melts were run in 200 mM ionic strength 
solutions containing perchlorate (pentagon), chloride (▼), and sulfate (hexagon). 
 
Pertaining to data from Chapter 6: 
 
DLS temperature ramps were run from 35 to 92 ⁰C at a ramp rate of 1 ⁰C/min using a 
Malvern ZS90 Zetasizer (Worchestershire, U.K.). Two 30 second acquisitions were 
collected and averaged at each temperature. The melting temperature was determined as 
the temperature where the DLS diameter spiked. Figures C2 show representative DLS 





Figure C2: DLS temperature ramps performed in (A) buffer and (B) sucrose. The 
temperature at which the Z-average diameter spikes is the melting temperature.  
 
All melts performed showed a fairly steady baseline diameter followed by a large 
spike in the DLS diameter upon melting. Overtime the DLS diameter decreases due to 
aggregates precipitating and leaving the DLS’s field of vision.  
This set of experiments was performed to study the unfolding intermediate using a 
different protein melting technique; however, DLS is insensitive to changes in protein 
secondary and tertiary structure, so the intermediate was not captured. Further, we found 
that DLS could not distinguish between different sugar solutions (see Table C1). The 
difference in melting temperature between these results and CD melting temperatures 
reported are due to difference in convention in determining Tm. The DLS results do 
confirm that sugars stabilize the IgG1 compared to buffer alone.  
 
Table C1: Collection of DLS melts for selected sugars and other excipients. ΔTm = Tm, 
Excipient – Tm,Buffer. 
Excipient Onset of melt (°C) ΔTm (°C) 
Buffer 60 - 
Trehalose 64 4 
Sucrose 64 4 
Glucose 64 4 
Sorbitol 63 3 
Mannitol 65 5 
Glycerol 63 3 





Figure D1: Stegosaurus, meaning “covered lizard.” These are plant eaters that can grow up to 30 feet 
long and 4.5 metric tons. They have a single, tiny brain (previously thought to have second brain in 
their tail). They lived in the late Jurassic period. This is my favorite dinosaur. Image taken from < 
http://www.wikidino.com/wp-content/uploads/Stegosaurus-marciolcastro.jpg >, accessed on 
February 7, 2013. 
 
 
Figure D2: Edmontosaurus was a 4.0 metric ton, small brained, biped herbivore that used to live in 
Alberta, Canada during the late Cretaceous period. They are thought to run at speeds of up to 28 
mph. These animals lived in herds and were likely prey for by T. Rex. Image taken from 
<http://en.wikipedia.org/wiki/File:Edmontosaurus_BW.jpg>, accessed on February 6, 2013. 
 
 
Figure D3: Monoclonius were 6 foot long, herding herbivores. They lived during the late Cretaceous 
period. Current thinking suggests that Monoclonius are improperly classified as a unique species, 
rather they are simply juvenile Centrosaurus; however, no one can tell for sure so the taxonomical 
distinction remains. Image taken from <http://www.kidsdinos.com/dinosaurs-for-
children.php?dinosaur=Monoclonius>, accessed on February 6, 2013.  
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APPENDIX E 
REFRCATIVE INDICES OF SALINE AND SACHHARIDE 
SOLUTIONS AND VISCOSITY OF SACCHARIDE SOLUTION 
Data pertaining to Chapter 4’s saline solutions:  
 
 
Figure E1: Refractive index values measured and used for this work using a digital 
Libby Refractometer at 25°C. 100 mM sodium acetate at pH 4.5 was the background 






Data pertaining to Chapter 6 and saccharides: 
 
Refractive index measurements were conducted at 20 °C using a digital Libby 
refractometer (Figure S1). The buffer alone gave a refractive index of 1.3342 (y-
intercept). 
 
Figure E1: Refractive index measurements of a variety of sugars in buffer (25 mM 
acetate, 150 mM sodium chloride, pH 5.5) 
 
Table E4: Presented are the slopes of the curves shown in Figure S1 and the refractive 
index at 500 mM of each sugar. The y-intercept for all curves was 1.3342 (i.e. buffer). 
Sugar dn/dc  (M
-1
) RI @ 500 mM 
Fructose 0.0248 1.3468 
Glucose 0.0263 1.34752 
Maltose 0.048 1.35915 
Mannitol 0.026 1.3472 
Sorbitol 0.0262 1.34757 
Sucrose 0.05 1.35955 
Trehalose 0.05 1.36034 
Xylitol 0.02 1.34457 
 
The viscosities η of 500 mM sugar solutions were inferred using 200 nm standard 
polystyrene (PS) particles (Bangs Laboratories Inc., Fishers, Indiana). The actual 
hydrodynamic radius of the particle will not change in different saccharide solutions; 
however, if viscosity is not entered accurately, the dynamic light scattering (DLS) 
instrument will output an Rh larger than the real size. The Einstein-Stokes equation relates 





       (Equation E1) 
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where kBT is the thermal unit and D is the mutual diffusion coefficient. Using this 
relation, we can determine η if we know the actual Rh and measure the spuriously high 
apparent hydrodynamic radius Rh, app.  
The PS particles’ Rh in buffer was determined using a Malvern Zetasizer ZS90 
(Worcestershire, UK) to be 205 nm. In sucrose, for example, Rh, app was 337 nm. DLS 
directly measures D, so this value is accurate and constant regardless of the inputted 








































   (Equation E2) 
 
Using equation E2 we determined the viscosities in Table E2.  
 
Table E5: Viscosity of 500 mM sugar solutions at 25 ⁰C 
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